Sign In

Login

Password

Forgot Password ? Sign Up

Covid-19 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Covid-19" in Czech language version.

refsWebsite
Global rank Czech rank
92doi.org
2nd place
4th place
51nih.gov
4th place
8th place
22worldcat.org
5th place
3rd place
19web.archive.org
1st place
1st place
17medicalxpress.com
8,255th place
77th place
16who.int
195th place
168th place
13nature.com
234th place
72nd place
12cdc.gov
218th place
304th place
6semanticscholar.org
11th place
313th place
5nytimes.com
7th place
43rd place
5elsevier.com
610th place
203rd place
4osel.cz
7,480th place
47th place
4washingtonpost.com
34th place
133rd place
4sciencedirect.com
149th place
80th place
4aazdravi.cz
low place
low place
4novinky.cz
1,270th place
5th place
4irozhlas.cz
3,217th place
16th place
4medrxiv.org
low place
low place
4thelancet.com
2,393rd place
974th place
3ceskatelevize.cz
1,281st place
6th place
3nejm.org
2,374th place
1,252nd place
3jamanetwork.com
2,650th place
1,128th place
3denik.cz
2,040th place
11th place
3ourworldindata.org
2,263rd place
2,302nd place
3europa.eu
68th place
38th place
3bmj.com
1,226th place
800th place
2arcgis.com
2,359th place
263rd place
2idnes.cz
442nd place
2nd place
2sciencealert.com
5,043rd place
5,560th place
2springer.com
274th place
174th place
2covid19criticalcare.com
low place
low place
2remedia.cz
low place
2,835th place
2biorxiv.org
5,061st place
884th place
2clinicaltrials.gov
5,225th place
2,661st place
2bbc.com
20th place
48th place
2theguardian.com
12th place
39th place
2seznamzpravy.cz
4,711th place
29th place
2kff.org
low place
low place
2asm.org
3,555th place
1,232nd place
2guidetopharmacology.org
low place
low place
1uzis.cz
low place
568th place
1hmri.org.au
low place
low place
1mayoclinic.org
1,610th place
820th place
1racgp.org.au
low place
low place
1health.gov.au
low place
4,496th place
1aktualne.cz
2,459th place
13th place
1cnn.com
28th place
74th place
1iflscience.com
low place
7,657th place
1gov.cz
low place
213th place
1kebijakankesehatanindonesia.net
low place
low place
1mit.edu
415th place
684th place
1heraldopenaccess.us
low place
low place
1plos.org
2,112th place
284th place
1wiley.com
222nd place
83rd place
1worldometers.info
2,099th place
955th place
1aa.com.tr
754th place
3,840th place
1scmp.com
362nd place
1,155th place
1apatykar.info
low place
low place
1zdravotnickydenik.cz
low place
1,824th place
1denikn.cz
low place
116th place
1swissinfo.ch
1,485th place
2,155th place
1pharmaceutical-technology.com
low place
low place
1sukl.cz
low place
373rd place
1biocon.com
low place
low place
1jst.go.jp
1,903rd place
5,340th place
1info.cz
low place
255th place
1sciencemag.org
857th place
315th place
1cancer.gov
1,684th place
3,086th place
1elpais.com
84th place
706th place
1rt.com
1,021st place
827th place
1ox.ac.uk
613th place
692nd place
1bnnbloomberg.ca
low place
low place
1icm-mhi.org
low place
low place
1globes.co.il
1,102nd place
8,055th place
1thoughteconomics.com
low place
low place
1merck.com
6,464th place
1,959th place
1infekce.cz
low place
2,370th place
1recoverytrial.net
low place
low place
1fda.gov
447th place
753rd place
1regeneron.com
low place
low place
1ibr-inc.com
low place
low place
1techfocus.cz
low place
2,453rd place
1cell.com
2,814th place
593rd place
1time.com
61st place
147th place
1czechsight.cz
low place
low place
1ilmessaggero.it
1,738th place
low place
1ria.ru
183rd place
566th place
1lji.org
low place
low place
1reuters.com
49th place
92nd place
1healthline.com
3,733rd place
1,015th place
1ashpublications.org
low place
low place
1google.cz
low place
390th place
1cureus.com
low place
low place
1scientificamerican.com
896th place
558th place
1iniciativa-snih.cz
low place
low place
1statnews.com
8,771st place
9,528th place
1iprima.cz
8,156th place
57th place
1thailandmedical.news
low place
low place
1lidovky.cz
2,549th place
14th place
1harvard.edu
18th place
99th place
1nyc.gov
1,074th place
1,926th place
1ssrn.com
703rd place
1,110th place
1medium.com
551st place
618th place
1fzone.cz
low place
low place
1twitter.com
23rd place
106th place
1yiigle.com
low place
low place
1chinacdc.cn
low place
low place
1mzcr.cz
low place
573rd place
1independent.co.uk
36th place
101st place
1health.org.uk
low place
low place
1sciencedaily.com
993rd place
481st place
1seattletimes.com
519th place
1,194th place
1yookee.cz
low place
low place
1theadvocate.com
3,159th place
low place
1bubinekrevolveru.cz
low place
1,078th place
1cestina20.cz
low place
2,436th place

aa.com.tr

  • UL KHALIQ, Riyaz. China begins publishing COVID-19 asymptomatic cases. Anadolu Agency [online]. 2020-04-01 [cit. 2020-10-28]. Dostupné online. (anglicky) 

aazdravi.cz

  • VAVRENKA, Petr. Lékaři odhalili příznak Covidu-19, který se objevuje jako první, především u seniorů. AAzdraví.cz [online]. 2020-11-11 [cit. 2020-11-20]. Dostupné online. 
  • MAJEROVÁ, Veronika. Probouzíte se zpocení? Může to být koronavirus, seznamte se s méně známými příznaky. aazdraví.cz [online]. 2020-11-30 [cit. 2020-12-27]. Dostupné online. 
  • VAVRENKA, Petr. Úmrtnost na koronavirus je šestkrát nižší v zemích, které očkují proti TBC, potvrdili vědci. Česko mezi ně patří. aazdravi.cz [online]. 2020-04-09 [cit. 2020-10-28]. Dostupné online. 
  • VAVRENKA, Petr. Lékaři se obávají, že jeden nepříjemný symptom mohou pacienti po překonání covidu-19 pociťovat už navždy. aazdravi.cz [online]. 2021-01-30 [cit. 2021-05-08]. Dostupné online. 

aktualne.cz

zpravy.aktualne.cz

  • KLÉZL, Tomáš. Vir se šíří jako kouř. V nevětrané místnosti rozestupy nefungují, říká rektor ČVUT. [[Aktuálně.cz|Aktuálně.cz]] [online]. [[Economia|Economia]], 2020-10-20 [cit. 2021-03-09]. Dostupné online. 

apatykar.info

lekarenstvi.apatykar.info

  • Možný lék na COVID-19 – superpočítače hlásí slibné výsledky. lekarenstvi.apatykar.info [online]. apatykar.info, 2020-06-23 [cit. 2020-10-28]. Dostupné online. 

arcgis.com

gisanddata.maps.arcgis.com

ashpublications.org

  • MACALLAN, Derek C.; WALLACE, Diana L.; ZHANG, Yan; GHATTAS, Hala; ASQUITH, Becca; DE LARA, Catherine; WORTH, Andrew. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. S. 3633–3640. Blood [online]. 2005-05-01 [cit. 2021-02-23]. Roč. 105, čís. 9, s. 3633–3640. Dostupné online. DOI 10.1182/blood-2004-09-3740. (anglicky) 

asm.org

mbio.asm.org

  • AGOSTINI, Maria L.; ANDRES, Erica L.; SIMS, Amy C.; GRAHAM, Rachel L.; SHEAHAN, Timothy P.; LU, Xiaotao; SMITH, Everett Clinton. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio [online]. 2018-03-06 [cit. 2020-10-27]. Roč. 9, čís. 2. Dostupné v archivu pořízeném z originálu dne 2020-11-01. DOI 10.1128/mBio.00221-18. (anglicky) 

jvi.asm.org

  • IWATA-YOSHIKAWA, Naoko; OKAMURA, Tadashi; SHIMIZU, Yukiko; HASEGAWA, Hideki; TAKEDA, Makoto; NAGATA, Noriyo. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. S. e01815–18, /jvi/93/6/JVI.01815–18.atom. Journal of Virology [online]. 2019-01-09 [cit. 2020-10-28]. Roč. 93, čís. 6, s. e01815–18, /jvi/93/6/JVI.01815–18.atom. Dostupné v archivu pořízeném z originálu dne 2020-11-13. DOI 10.1128/JVI.01815-18. (anglicky) 

bbc.com

  • GALLAGHER, James. Covid immunity: Can you catch it twice?. BBC News [online]. 2021-01-14 [cit. 2021-05-08]. Dostupné online. (anglicky) 
  • BUTCHER, Benjamin; MASSEY, Joel. Why are more BAME people dying from coronavirus?. BBC News Online. 9 June 2020. Dostupné online [cit. 10 June 2020]. 

biocon.com

  • Biocon’s Breakthrough Drug Itolizumab Receives DCGI Nod for its Use in Moderate to Severe COVID-19 Patients [online]. Biocon, 2020-07-11 [cit. 2020-10-27]. Dostupné online. (anglicky) 

biorxiv.org

  • MATSUYAMA, Shutoku; KAWASE, Miyuki; NAO, Naganori; SHIRATO, Kazuya; UJIKE, Makoto; KAMITANI, Wataru; SHIMOJIMA, Masayuki. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. bioRxiv preprint [online]. 2020-03-12 [cit. 2020-10-28]. Dostupné online. DOI 10.1101/2020.03.11.987016. (anglicky) 
  • ZHANG, Liguo; RICHARDS, Alexsia; KHALIL, Andrew; WOGRAM, Emile; MA, Haiting; YOUNG, Richard A.; JAENISCH, Rudolf. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome. BioXriv [online]. 2020-12-13 [cit. 2024-01-02]. Dostupné online. DOI 10.1101/2020.12.12.422516. (anglicky) 

bmj.com

bmj.com

  • DAY, Michael. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ [online]. 2020-04-02 [cit. 2020-10-28]. Dostupné online. DOI 10.1136/bmj.m1375. (anglicky) 
  • SHAH, Waqaar; HILLMAN, Toby; PLAYFORD, E Diane; HISHMEH, Lyth. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ [online]. 2021-01-22. Dostupné online. DOI 10.1136/bmj.n136. (anglicky) 

bmjopen.bmj.com

bnnbloomberg.ca

  • COURT, Emma. Merck pushes ahead on COVID-19 treatment, vaccines. bnnbloomberg.ca [online]. 2020-07-31 [cit. 2024-01-02]. Dostupné online. (anglicky) 

bubinekrevolveru.cz

  • DRDA, Adam. Diktatura národního zdraví (Poznámky napsané ve stavu nouze). www.bubinekrevolveru.cz [online]. 2020-04-06 [cit. 2020-10-28]. Dostupné online. 

cancer.gov

  • NCI Drug Dictionary: recombinant human angiotensin converting enzyme 2 APN01 [online]. cancer.gov, 2011-02-02 [cit. 2020-10-28]. Dostupné online. (anglicky) 

cdc.gov

  • CDC. Coronavirus Disease 2019 (COVID-19) [online]. [cit. 2020-10-22]. Dostupné online. 
  • How COVID-19 Spreads [online]. 18 September 2020 [cit. 2020-09-20]. Dostupné v archivu pořízeném z originálu dne 19 September 2020. 
  • Frequently Asked Questions [online]. Centers for Disease Control and Prevention, rev. 2021-02-08 [cit. 2021-02-23]. Dostupné online. (anglicky) 
  • WEI, Wycliffe E.; LI, Zongbin; CHIEW, Calvin J.; YONG, Sarah E.; TOH, Matthias P.; LEE, Vernon J. Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020. S. 411–415. MMWR. Morbidity and Mortality Weekly Report [online]. 2020-04-10 [cit. 2020-10-28]. Roč. 69, čís. 14, s. 411–415. Dostupné online. DOI 10.15585/mmwr.mm6914e1. (anglicky) 
  • Symptoms of Coronavirus | CDC. www.cdc.gov [online]. 2020-01-23, rev. 2020-05-13 [cit. 2020-09-12]. Dostupné online. (anglicky) 
  • CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention [online]. 2020-02-11 [cit. 2020-03-24]. Dostupné online. (anglicky) 
  • ((Centers for Disease Control and Prevention)). Principles of Epidemiology in Public Health Practice. Third. vyd. [s.l.]: U.S. Centers for Disease Control and Prevention (CDC), May 2012. No. SS1978. Kapitola Lesson 3: Measures of Risk Section 3: Mortality Frequency Measures. 
  • Dostupné online. 
  • Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Yousey-Hindes K, Niccolai L, Anderson EJ, Openo KP, Weigel A, Monroe ML, Ryan P, Henderson J, Kim S, Como-Sabetti K, Lynfield R, Sosin D, Torres S, Muse A, Bennett NM, Billing L, Sutton M, West N, Schaffner W, Talbot HK, Aquino C, George A, Budd A, Brammer L, Langley G, Hall AJ, Fry A. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, 1–30 March 2020. MMWR. Morbidity and Mortality Weekly Report. April 2020, s. 458–464. Dostupné online. DOI 10.15585/mmwr.mm6915e3. PMID 32298251. 
  • Coronavirus Disease 2019 (COVID-19) [online]. 11 February 2020 [cit. 2020-06-19]. Dostupné online. 
  • Coronavirus Disease 2019 (COVID-19) [online]. 11 February 2020 [cit. 2020-05-04]. Dostupné online. 
  • Coronavirus Disease 2019 (COVID-19) [online]. 11 February 2020. Dostupné online. 

cell.com

  • GRIFONI, Alba; WEISKOPF, Daniela; RAMIREZ, Sydney I.; MATEUS, Jose; DAN, Jennifer M.; MODERBACHER, Carolyn Rydyznski; RAWLINGS, Stephen A. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. S. 1489–1501.e15. Cell [online]. 2020-05-14 [cit. 2020-10-28]. Roč. 181, čís. 7, s. 1489–1501.e15. Dostupné online. DOI 10.1016/j.cell.2020.05.015. (anglicky) 

ceskatelevize.cz

ct24.ceskatelevize.cz

  • 30 otázek a odpovědí, které přinesly 3 měsíce s novým koronavirem. Kapitola Jak se nový koronavirus přenáší?. [[ČT24|ČT24]] [online]. Česká televize, 2020-03-19 [cit. 2020-03-25]. Dostupné online. 
  • ket. Počet obětí koronaviru šplhá ke dvěma tisícům. Nakažení jsou i Američané evakuovaní z lodi v Japonsku. ČT24 [online]. Česká televize, 2020-02-17 [cit. 2020-02-17]. Dostupné online. 
  • Čeští vědci jsou na stopě tomu, jak zabránit cytokinové bouři. Ta při covidu obrátí imunitu proti nemocnému. ČT24 [online]. Česká televize, 2020-07-05 [cit. 2020-10-28]. Dostupné online. 

cestina20.cz

  • čínská chřipka. Čeština 2.0 [online]. [cit. 2020-05-05]. Dostupné online. 

chinacdc.cn

weekly.chinacdc.cn

clinicaltrials.gov

  • Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia. ClinicalTrials.gov [online]. [cit. 2020-10-28]. Dostupné online. (anglicky) 
  • Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults – Full Text View [online]. clinicaltrials.gov, 2020-11-12, rev. 2020-12-10 [cit. 2020-12-27]. Dostupné online. (anglicky) 

cnn.com

edition.cnn.com

  • FOX, Maggie. Boston biotech conference led to 245,000 Covid-19 cases across US, genetic fingerprinting shows. CNN [online]. 2020-12-11 [cit. 2020-12-27]. Dostupné online. (anglicky) 

covid19criticalcare.com

cureus.com

  • SHENAI, Mahesh B; RAHME, Ralph; NOORCHASHM, Hooman. Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis. Cureus [online]. 2021-10-28. Dostupné online. DOI 10.7759/cureus.19102. (anglicky) 

czechsight.cz

  • Imunizace proti koronaviru není stoprocentní. Je možné se nakazit opětovně. Czechsight [online]. 4. února 2020 [cit. 2020-04-05]. Dostupné v archivu pořízeném z originálu dne 2020-05-20. 

denik.cz

  • HRABAL, Michal. Paměťová imunita chrání lidi po prodělání covidu i po roce, tvrdí vědkyně. Deník.cz [online]. Vltava Labe Media, 2021-01-04 [cit. 2021-01-10]. Dostupné online. 
  • KRUPKA, Jaroslav. Vědci zjistili, co stojí za těžkým průběhem covidu. Na vině je omyl protilátek. Deník.cz [online]. 2021-01-31 [cit. 2021-02-23]. Dostupné online. 
  • POLACZYKOVÁ, Tereza. Koronavirus má vážné dopady i na mozek. Pitvy odhalily děsivá poškození. Deník.cz [online]. 2021-01-09 [cit. 2021-02-23]. Dostupné online. 

denikn.cz

  • SKOUPÁ, Adéla. Komu nepomůže remdesivir ani kyslík, může zabrat plazma od vyléčených. Odpovídáme, kdo ji může darovat a co pro to má udělat. Deník N [online]. 2020-10-19 [cit. 2020-10-28]. Dostupné online. 

doi.org

dx.doi.org

  • Ye Q, Wang B, Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. The Journal of Infection. June 2020, s. 607–613. ISSN 0163-4453. DOI 10.1016/j.jinf.2020.03.037. PMID 32283152. 
  • Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, Guaraldi G, Mussini C, Gudiol C, Pujol M, Bandera A, Scudeller L, Paul M, Kaiser L, Leibovici L. Long-term consequences of COVID-19: research needs. The Lancet. Infectious Diseases. September 2020, s. 1115–1117. DOI 10.1016/S1473-3099(20)30701-5. PMID 32888409. 
  • SENDER, Ron; BAR-ON, Yinon M.; GLEIZER, Shmuel; BERNSHTEIN, Biana; FLAMHOLZ, Avi; PHILLIPS, Rob; MILO, Ron. The total number and mass of SARS-CoV-2 virions. Proceedings of the National Academy of Sciences [online]. 2021-06-22. Roč. 118, čís. 25. Dostupné online. DOI 10.1073/pnas.2024815118. PMID 34083352. (anglicky) 
  • SNIJDER, Eric J.; BREDENBEEK, Peter J.; DOBBE, Jessika C.; THIEL, Volker; ZIEBUHR, John; POON, Leo L.M.; GUAN, Yi. Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. S. 991–1004. Journal of Molecular Biology [online]. 2003-08 [cit. 2020-10-30]. Roč. 331, čís. 5, s. 991–1004. Dostupné online. DOI 10.1016/S0022-2836(03)00865-9. (anglicky) 
  • WEI, Wycliffe E.; LI, Zongbin; CHIEW, Calvin J.; YONG, Sarah E.; TOH, Matthias P.; LEE, Vernon J. Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020. S. 411–415. MMWR. Morbidity and Mortality Weekly Report [online]. 2020-04-10 [cit. 2020-10-28]. Roč. 69, čís. 14, s. 411–415. Dostupné online. DOI 10.15585/mmwr.mm6914e1. (anglicky) 
  • The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine [online]. American College of Physicians, 2020-03-10 [cit. 2020-03-25]. Dostupné v archivu pořízeném dne 2020-03-24. ISSN 1539-3704. DOI 10.7326/M20-0504. (anglicky) 
  • Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open [online]. BMJ Publishing Group, 2020-08-16 [cit. 2021-02-13]. Dostupné online. ISSN 2044-6055. DOI 10.1136/bmjopen-2020-039652. (anglicky) 
  • JAVIER C, Vázquez. Delirium In Severe Acute Respiratory Syndrome-Coronavirus-2 Infection: A Point Of View. S. 1–5. Clinical Immunology and Immunotherapy [online]. 2020-09-07 [cit. 2020-11-20]. Roč. 6, čís. 4, s. 1–5. Dostupné online. DOI 10.24966/CIIT-8844/1000039. (anglicky) 
  • GRANT, Michael C.; GEOGHEGAN, Luke; ARBYN, Marc; MOHAMMED, Zakaria; MCGUINNESS, Luke; CLARKE, Emily L. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE [online]. 2020-06-23 [cit. 2020-09-12]. Dostupné online. DOI 10.1371/journal.pone.0234765. (anglicky) 
  • HAN, Chaoqun; DUAN, Caihan; ZHANG, Shengyan; SPIEGEL, Brennan; SHI, Huiying; WANG, Weijun; ZHANG, Lei. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes. S. 916–923. American Journal of Gastroenterology [online]. 2020-06 [cit. 2021-01-05]. Roč. 115, čís. 6, s. 916–923. Dostupné online. DOI 10.14309/ajg.0000000000000664. PMID 32301761. (anglicky) 
  • CHEN, Chen; ZHOU, Yiwu; WANG, Dao Wen. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. S. 230–232. Herz [online]. 2020-03-05 [cit. 2020-10-28]. Roč. 45, čís. 3, s. 230–232. Dostupné online. DOI 10.1007/s00059-020-04909-z. (anglicky) 
  • KLOK, F.A.; KRUIP, M.J.H.A.; VAN DER MEER, N.J.M.; ARBOUS, M.S.; GOMMERS, D.A.M.P.J.; KANT, K.M.; KAPTEIN, F.H.J. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. S. 145–147. Thrombosis Research [online]. 2020-04-10 [cit. 2020-10-28]. Roč. 191, čís. 7/2020, s. 145–147. Dostupné online. DOI 10.1016/j.thromres.2020.04.013. PMID 32291094. (anglicky) 
  • TANG, Ning; LI, Dengju; WANG, Xiong; SUN, Ziyong. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. S. 844–847. Journal of Thrombosis and Haemostasis [online]. 2020-02-18 [cit. 2020-10-28]. Roč. 18, čís. 4/2020, s. 844–847. Dostupné online. DOI 10.1111/jth.14768. (anglicky) 
  • SWADLING, Leo; DINIZ, Mariana O.; SCHMIDT, Nathalie M.; AMIN, Oliver E.; CHANDRAN, Aneesh; SHAW, Emily; PADE, Corinna. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. S. 110–117. Nature [online]. 2022-01-06. Roč. 601, čís. 7891, s. 110–117. Dostupné online. DOI 10.1038/s41586-021-04186-8. (anglicky) 
  • DAY, Michael. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ [online]. 2020-04-02 [cit. 2020-10-28]. Dostupné online. DOI 10.1136/bmj.m1375. (anglicky) 
  • PAIRO-CASTINEIRA, Erola; CLOHISEY, Sara; KLARIC, Lucija; BRETHERICK, Andrew D.; RAWLIK, Konrad; PASKO, Dorota; WALKER, Susan. Genetic mechanisms of critical illness in Covid-19. Nature [online]. 2020-12-11 [cit. 2020-12-27]. Dostupné online. DOI 10.1038/s41586-020-03065-y. (anglicky) 
  • WU, Canrong; LIU, Yang; YANG, Yueying; ZHANG, Peng; ZHONG, Wu; WANG, Yali; WANG, Qiqi. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. S. 766–788. Acta Pharmaceutica Sinica B [online]. 2020-02-18 [cit. 2020-10-28]. Roč. 10, čís. 5/2020, s. 766–788. Dostupné online. DOI 10.1016/j.apsb.2020.02.008. (anglicky) 
  • KORY, Pierre; MEDURI, G. Umberto; IGLESIAS, Jose; VARON, Joseph; MARIK, Paul E. Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19. S. 135–156. Journal of Intensive Care Medicine [online]. 2020-12-15 [cit. 2021-02-26]. Roč. 36, čís. 2, s. 135–156. Dostupné v archivu pořízeném z originálu dne 2021-02-14. DOI 10.1177/0885066620973585. (anglicky) 
  • KORY, Pierre; MEDURI, Gianfranco Umberto; VARON, Joseph; IGLESIAS, Jose; MARIK, Paul E. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. S. e299–e318. American Journal of Therapeutics [online]. 2021-05. Roč. 28, čís. 3, s. e299–e318. Dostupné online. DOI 10.1097/MJT.0000000000001377. PMID 34375047. (anglicky) 
  • CALY, Leon; DRUCE, Julian D.; CATTON, Mike G.; JANS, David A.; WAGSTAFF, Kylie M. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. S. 104787. Antiviral Research [online]. 2020-04-03 [cit. 2020-10-28]. Roč. 178, čís. 6/2020, s. 104787. Dostupné online. DOI 10.1016/j.antiviral.2020.104787. (anglicky) 
  • AGOSTINI, Maria L.; ANDRES, Erica L.; SIMS, Amy C.; GRAHAM, Rachel L.; SHEAHAN, Timothy P.; LU, Xiaotao; SMITH, Everett Clinton. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio [online]. 2018-03-06 [cit. 2020-10-27]. Roč. 9, čís. 2. Dostupné v archivu pořízeném z originálu dne 2020-11-01. DOI 10.1128/mBio.00221-18. (anglicky) 
  • GORDON, Calvin J.; TCHESNOKOV, Egor P.; FENG, Joy Y.; PORTER, Danielle P.; GÖTTE, Matthias. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. S. 4773–4779. Journal of Biological Chemistry [online]. 2020-04-10 [cit. 2020-10-27]. Roč. 295, čís. 15, s. 4773–4779. Dostupné online. DOI 10.1074/jbc.AC120.013056. PMID 32094225. (anglicky) 
  • WANG, Manli; CAO, Ruiyuan; ZHANG, Leike; YANG, Xinglou; LIU, Jia; XU, Mingyue; SHI, Zhengli. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. S. 269–271. Cell Research [online]. 2020-03 [cit. 2020-10-27]. Roč. 30, čís. 3, s. 269–271. Dostupné online. DOI 10.1038/s41422-020-0282-0. (anglicky) 
  • HENNIGAN, Stephanie; KAVANAUGH, Arthur. Interleukin-6 inhibitors in the treatment of rheumatoid arthritis. S. 767–775. Therapeutics and Clinical Risk Management [online]. 2008-08-08 [cit. 2020-10-27]. Roč. 2008, čís. August 4(4), s. 767–775. Dostupné online. DOI 10.2147/tcrm.s3470. PMID 19209259. (anglicky) 
  • COOMES, Eric Anthony; HAGHBAYAN, Hourmazd. Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis. S. 2020.03.30.20048058. medRxiv [online]. 2020-04-03 [cit. 2020-10-27]. S. 2020.03.30.20048058. Dostupné online. DOI 10.1101/2020.03.30.20048058. (anglicky) 
  • FREITAS, Raquel Filipa; BASTO, Afonso; ALMEIDA, Silvia C.P.; SANTOS, Rita F.; GONÇALVES, Carine M.; CORRIA-OSORIO, Jesus; CARVALHO, Tânia. Modulation of CD4 T cell function via CD6-targeting. S. 427–435. EBioMedicine [online]. 2019-09 [cit. 2020-10-27]. Roč. 47, s. 427–435. Dostupné online. DOI 10.1016/j.ebiom.2019.08.008. PMID 31481324. (anglicky) 
  • AXFORS, Cathrine; SCHMITT, Andreas M.; JANIAUD, Perrine; VAN’T HOOFT, Janneke; ABD-ELSALAM, Sherief; ABDO, Ehab F.; ABELLA, Benjamin S. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. S. 2349. Nature Communications [online]. 2021-04-15. Roč. 12, čís. 1, s. 2349. Dostupné online. DOI 10.1038/s41467-021-22446-z. (anglicky) 
  • GAO, Jianjun; TIAN, Zhenxue; YANG, Xu. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. S. 72–73. BioScience Trends [online]. 2020-02-29 [cit. 2020-10-28]. Roč. 14, čís. 1, s. 72–73. Dostupné online. ISSN 1881-7815. DOI 10.5582/bst.2020.01047. (anglicky) 
  • TAHVILDARI, Azin; ARBABI, Mahta; FARSI, Yeganeh; JAMSHIDI, Parnian; HASANZADEH, Saba; CALCAGNO, Tess Moore; NASIRI, Mohammad Javad. Clinical features, Diagnosis, and Treatment of COVID-19: A systematic review of case reports and case series. medRxiv preprint [online]. 2020-04-03 [cit. 2020-10-28]. Dostupné online. DOI 10.1101/2020.03.28.20046151. (anglicky) 
  • RICHARDSON, Peter; GRIFFIN, Ivan; TUCKER, Catherine; SMITH, Dan; OECHSLE, Olly; PHELAN, Anne; RAWLING, Michael. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. S. 30–e31. The Lancet [online]. 2020-02-15 [cit. 2020-10-28]. Roč. 395, čís. 10223, s. 30–e31. Dostupné online. DOI 10.1016/S0140-6736(20)30304-4. (anglicky) 
  • IWATA-YOSHIKAWA, Naoko; OKAMURA, Tadashi; SHIMIZU, Yukiko; HASEGAWA, Hideki; TAKEDA, Makoto; NAGATA, Noriyo. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. S. e01815–18, /jvi/93/6/JVI.01815–18.atom. Journal of Virology [online]. 2019-01-09 [cit. 2020-10-28]. Roč. 93, čís. 6, s. e01815–18, /jvi/93/6/JVI.01815–18.atom. Dostupné v archivu pořízeném z originálu dne 2020-11-13. DOI 10.1128/JVI.01815-18. (anglicky) 
  • YAMAMOTO, Mizuki; MATSUYAMA, Shutoku; LI, Xiao; TAKEDA, Makoto; KAWAGUCHI, Yasushi; INOUE, Jun-ichiro; MATSUDA, Zene. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. S. 6532–6539. Antimicrobial Agents and Chemotherapy [online]. 2016-10-21 [cit. 2020-10-28]. Roč. 60, čís. 11, s. 6532–6539. Dostupné online. DOI 10.1128/AAC.01043-16. PMID 27550352. (anglicky) 
  • CHEN, Yu Wai; YIU, Chin-Pang Bennu; WONG, Kwok-Yin. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. S. 129. F1000Research [online]. 2020-04-09 [cit. 2020-10-28]. Roč. 9, s. 129. DOI 10.12688/f1000research.22457.2. PMID 32194944. (anglicky) 
  • ROSSIGNOL, Jean-François. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. S. 227–230. Journal of Infection and Public Health [online]. 2016-05 [cit. 2020-10-28]. Roč. 9, čís. 3, s. 227–230. Dostupné online. DOI 10.1016/j.jiph.2016.04.001. PMID 27095301. (anglicky) 
  • MATSUYAMA, Shutoku; KAWASE, Miyuki; NAO, Naganori; SHIRATO, Kazuya; UJIKE, Makoto; KAMITANI, Wataru; SHIMOJIMA, Masayuki. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. bioRxiv preprint [online]. 2020-03-12 [cit. 2020-10-28]. Dostupné online. DOI 10.1101/2020.03.11.987016. (anglicky) 
  • COX, Robert M.; WOLF, Josef D.; PLEMPER, Richard K. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. S. 11–18. Nature Microbiology [online]. 2021-01 [cit. 2021-02-23]. Roč. 6, čís. 1, s. 11–18. Dostupné online. DOI 10.1038/s41564-020-00835-2. (anglicky) 
  • MILLER, Aaron; REANDELAR, Mac Josh; FASCIGLIONE, Kimberly; ROUMENOVA, Violeta; LI, Yan; OTAZU, Gonzalo H. Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. medRxiv [online]. 2020-09-14 [cit. 2020-10-28]. Dostupné online. DOI 10.1101/2020.03.24.20042937. (anglicky) 
  • BRADLEY, Conor A. CD24 — a novel ‘don’t eat me’ signal. S. 541. Nature Reviews Cancer [online]. 2019-10. Roč. 19, čís. 10, s. 541. Dostupné online. DOI 10.1038/s41568-019-0193-x. (anglicky) 
  • BARKAL, Amira A.; BREWER, Rachel E.; MARKOVIC, Maxim; KOWARSKY, Mark; BARKAL, Sammy A.; ZARO, Balyn W.; KRISHNAN, Venkatesh. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. S. 392–396. Nature [online]. 2019-08 [cit. 2021-02-23]. Roč. 572, čís. 7769, s. 392–396. Dostupné online. DOI 10.1038/s41586-019-1456-0. (anglicky) 
  • SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 2019-08-01, roč. 36, čís. 8, s. 1878–1905. Dostupné online [cit. 2020-11-18]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764. (anglicky) 
  • Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2021-02-XX, roč. 397, čís. 10274, s. 605–612. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00149-5. PMID 33545096. (anglicky) 
  • Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet. 2021-05-14, s. S0140673621008977. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00897-7. (anglicky) 
  • THE RECOVERY COLLABORATIVE GROUP. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2020-11-19, roč. 383, čís. 21, s. 2030–2040. Dostupné online [cit. 2021-05-16]. ISSN 0028-4793. DOI 10.1056/NEJMoa2022926. PMID 33031652. (anglicky) 
  • HORBY, Peter W; MAFHAM, Marion; BELL, Jennifer L. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2020-10-XX, roč. 396, čís. 10259, s. 1345–1352. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(20)32013-4. PMID 33031764. (anglicky) 
  • THE RECOVERY COLLABORATIVE GROUP. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2021-02-25, roč. 384, čís. 8, s. 693–704. Dostupné online [cit. 2021-05-16]. ISSN 0028-4793. DOI 10.1056/NEJMoa2021436. PMID 32678530. (anglicky) 
  • THE WHO RAPID EVIDENCE APPRAISAL FOR COVID-19 THERAPIES (REACT) WORKING GROUP; STERNE, Jonathan A. C.; MURTHY, Srinivas. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020-10-06, roč. 324, čís. 13, s. 1330. Dostupné online [cit. 2021-05-16]. ISSN 0098-7484. DOI 10.1001/jama.2020.17023. PMID 32876694. (anglicky) 
  • Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2021-05-01, roč. 397, čís. 10285, s. 1637–1645. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00676-0. PMID 33933206. (anglicky) 
  • DAN, Jennifer M.; MATEUS, Jose; KATO, Yu; HASTIE, Kathryn M.; YU, Esther Dawen; FALITI, Caterina E.; GRIFONI, Alba. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. S. eabf4063. Science [online]. [cit. 2021-05-08]. Roč. 371, čís. 6529, s. eabf4063. Dostupné online. DOI 10.1126/science.abf4063. PMID 33408181. (anglicky) 
  • LE BERT, Nina; TAN, Anthony T.; KUNASEGARAN, Kamini; THAM, Christine Y. L.; HAFEZI, Morteza; CHIA, Adeline; CHNG, Melissa Hui Yen. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. S. 457–462. Nature [online]. 2020-08-20. Roč. 584, čís. 7821, s. 457–462. Dostupné online. DOI 10.1038/s41586-020-2550-z. (anglicky) 
  • GRIFONI, Alba; WEISKOPF, Daniela; RAMIREZ, Sydney I.; MATEUS, Jose; DAN, Jennifer M.; MODERBACHER, Carolyn Rydyznski; RAWLINGS, Stephen A. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. S. 1489–1501.e15. Cell [online]. 2020-05-14 [cit. 2020-10-28]. Roč. 181, čís. 7, s. 1489–1501.e15. Dostupné online. DOI 10.1016/j.cell.2020.05.015. (anglicky) 
  • VITALE, Josè; MUMOLI, Nicola; CLERICI, Pierangelo; DE PASCHALE, Massimo; EVANGELISTA, Isabella; CEI, Marco; MAZZONE, Antonino. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy. S. 1407. JAMA Internal Medicine [online]. 2021-10-01. Roč. 181, čís. 10, s. 1407. Dostupné online. DOI 10.1001/jamainternmed.2021.2959. (anglicky) 
  • TOWNSEND, Jeffrey P; HASSLER, Hayley B; WANG, Zheng; MIURA, Sayaka; SINGH, Jaiveer; KUMAR, Sudhir; RUDDLE, Nancy H. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. S. e666–e675. The Lancet Microbe [online]. 2021-12. Roč. 2, čís. 12, s. e666–e675. Dostupné online. DOI 10.1016/S2666-5247(21)00219-6. (anglicky) 
  • IKEZAKI, Hiroaki; NOMURA, Hideyuki; SHIMONO, Nobuyuki. Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers. Journal of Infection and Chemotherapy. 2022-06-01, roč. 28, čís. 6, s. 802–805. Dostupné online [cit. 2022-07-17]. ISSN 1341-321X. DOI 10.1016/j.jiac.2022.02.024. (anglicky) 
  • PULLIAM, Juliet R.C.; VAN SCHALKWYK, Cari; GOVENDER, Nevashan; VON GOTTBERG, Anne; COHEN, Cheryl; GROOME, Michelle J.; DUSHOFF, Jonathan. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. preprint [online]. 2021-11-11. Dostupné online. DOI 10.1101/2021.11.11.21266068. (anglicky) 
  • MACALLAN, Derek C.; WALLACE, Diana L.; ZHANG, Yan; GHATTAS, Hala; ASQUITH, Becca; DE LARA, Catherine; WORTH, Andrew. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. S. 3633–3640. Blood [online]. 2005-05-01 [cit. 2021-02-23]. Roč. 105, čís. 9, s. 3633–3640. Dostupné online. DOI 10.1182/blood-2004-09-3740. (anglicky) 
  • GAEBLER, Christian; WANG, Zijun; LORENZI, Julio C. C.; MUECKSCH, Frauke; FINKIN, Shlomo; TOKUYAMA, Minami; CHO, Alice. Evolution of antibody immunity to SARS-CoV-2. Nature [online]. 2021-01-18 [cit. 2021-02-23]. Dostupné online. DOI 10.1038/s41586-021-03207-w. (anglicky) 
  • SHENAI, Mahesh B; RAHME, Ralph; NOORCHASHM, Hooman. Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis. Cureus [online]. 2021-10-28. Dostupné online. DOI 10.7759/cureus.19102. (anglicky) 
  • SHAH, Waqaar; HILLMAN, Toby; PLAYFORD, E Diane; HISHMEH, Lyth. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ [online]. 2021-01-22. Dostupné online. DOI 10.1136/bmj.n136. (anglicky) 
  • DAVIDO, Benjamin; SEANG, Sophie; TUBIANA, Roland. Post–COVID-19 chronic symptoms: a postinfectious entity?. Clinical Microbiology and Infection. 2020-07-23. PMID: 32712242 PMCID: PMC7376333. Dostupné online [cit. 2020-09-07]. ISSN 1198-743X. DOI 10.1016/j.cmi.2020.07.028. PMID 32712242. 
  • ZHANG, Liguo; RICHARDS, Alexsia; KHALIL, Andrew; WOGRAM, Emile; MA, Haiting; YOUNG, Richard A.; JAENISCH, Rudolf. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome. BioXriv [online]. 2020-12-13 [cit. 2024-01-02]. Dostupné online. DOI 10.1101/2020.12.12.422516. (anglicky) 
  • KHAMSI, Roxanne. Rogue antibodies could be driving severe COVID-19. S. 29–31. Nature [online]. 2021-02-04. Roč. 590, čís. 7844, s. 29–31. Dostupné online. DOI 10.1038/d41586-021-00149-1. (anglicky) 
  • MULLARD, Asher. How COVID vaccines are being divvied up around the world. Canada leads the pack in terms of doses secured per capita.. Nature. 30 November 2020. Dostupné online [cit. 11 December 2020]. DOI 10.1038/d41586-020-03370-6. PMID 33257891. S2CID 227246811. 
  • SO, Anthony D; WOO, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. December 2020, s. m4750. ISSN 1756-1833. DOI 10.1136/bmj.m4750. PMID 33323376. 
  • VAN DOREMALEN, Neeltje; BUSHMAKER, Trenton; MORRIS, Dylan H. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020-03-17, roč. 0, čís. 0, s. null. Dostupné online [cit. 2020-04-11]. ISSN 0028-4793. DOI 10.1056/NEJMc2004973. PMID 32182409. 
  • MENEBO, Mesay Moges. Temperature and precipitation associate with Covid-19 new daily cases: A correlation study between weather and Covid-19 pandemic in Oslo, Norway. S. 139659. Science of The Total Environment [online]. 2020-10 [cit. 2020-10-28]. Roč. 737, s. 139659. Dostupné online. DOI 10.1016/j.scitotenv.2020.139659. (anglicky) 
  • Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatrics. April 2020, s. 882–889. Dostupné online. DOI 10.1001/jamapediatrics.2020.1467. PMID 32320004. 
  • Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z, Xiang Y, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S, Wong GW. SARS-CoV-2 Infection in Children. The New England Journal of Medicine. Massachusetts Medical Society, April 2020, s. 1663–1665. DOI 10.1056/nejmc2005073. PMID 32187458. 
  • Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. June 2020, s. e20200702. DOI 10.1542/peds.2020-0702. PMID 32179660. S2CID 219118986. 
  • Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. The Lancet. Global Health. May 2020, s. e641–e642. Dostupné online. DOI 10.1016/S2214-109X(20)30110-8. PMID 32199072. 
  • Mallapaty S. How deadly is the coronavirus? Scientists are close to an answer. Nature. 16 June 2020, s. 467–468. Dostupné online. DOI 10.1038/d41586-020-01738-2. PMID 32546810. S2CID 219726496. Bibcode 2020Natur.582..467M. 
  • Alwan N, Burgess R, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman L, Greenhalgh T, Gurdasani D, Hamdy A, Hanage W, Hodcroft E, Hyde Z, Kellam P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar D, Swanton C, Walensky R, Yamey G, Ziauddeen H. Scientific consensus on the COVID-19 pandemic: we need to act now. The Lancet. 31 October 2020, s. E71–E72. DOI 10.1016/S0140-6736(20)32153-X. PMID 33069277. 
  • Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. International Journal of Infectious Diseases. December 2020, s. 138–148. DOI 10.1016/j.ijid.2020.09.1464. PMID 33007452. 
  • Levin A, Hanage W, Owusu-Boaitey N, Cochran K, Walsh S, Meyerowitz-Katz G. Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications. European Journal of Epidemiology. December 2020, s. 1123–1138. DOI 10.1007/s10654-020-00698-1. PMID 33289900. 
  • WILSON, Linus. SARS-CoV-2, COVID-19, Infection Fatality Rate (IFR) Implied by the Serology, Antibody, Testing in New York City. SSRN Electronic Journal [online]. 2020-05. Dostupné online. DOI 10.2139/ssrn.3590771. (anglicky) 
  • Yang W, Kandula S, Huynh M, Greene SK, Van Wye G, Li W, Chan HT, McGibbon E, Yeung A, Olson D, Fine A, Shaman J. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. The Lancet. Infectious Diseases. October 2020. Dostupné online. DOI 10.1016/s1473-3099(20)30769-6. PMID 33091374. 
  • Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. February 2020, s. 507–513. DOI 10.1016/S0140-6736(20)30211-7. PMID 32007143. 
  • Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. March 2020, s. 846–848. DOI 10.1016/S0140-6736(20)30526-2. PMID 32151325. 
  • EPIDEMIOLOGY WORKING GROUP FOR NCIP EPIDEMIC RESPONSE, Chinese Center for Disease Control Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. February 2020, s. 145–151. Dostupné online. DOI 10.3760/cma.j.issn.0254-6450.2020.02.003. PMID 32064853. S2CID 211133882. (čamorsky) 
  • The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19). China CDC Weekly. February 2020, s. 113–122. Dostupné online [cit. 15 June 2020]. ISSN 2096-7071. DOI 10.46234/ccdcw2020.032. 
  • Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. Journal of Clinical Virology. June 2020, s. 104371. DOI 10.1016/j.jcv.2020.104371. PMID 32315817. 
  • Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. The Journal of Infection. June 2020, s. 656–665. DOI 10.1016/j.jinf.2020.03.041. PMID 32283155. 
  • Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clinical Immunology. June 2020, s. 108427. DOI 10.1016/j.clim.2020.108427. PMID 32325252. S2CID 216028003. 
  • Dorn AV, Cooney RE, Sabin ML. COVID-19 exacerbating inequalities in the US. Lancet. April 2020, s. 1243–1244. DOI 10.1016/S0140-6736(20)30893-X. PMID 32305087. 
  • Adams ML, Katz DL, Grandpre J. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States. Emerging Infectious Diseases. April 2020, s. 1831–1833. DOI 10.3201/eid2608.200679. PMID 32324118. 
  • Laurencin CT, McClinton A. The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities. Journal of Racial and Ethnic Health Disparities. April 2020, s. 398–402. DOI 10.1007/s40615-020-00756-0. PMID 32306369. 
  • Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Yousey-Hindes K, Niccolai L, Anderson EJ, Openo KP, Weigel A, Monroe ML, Ryan P, Henderson J, Kim S, Como-Sabetti K, Lynfield R, Sosin D, Torres S, Muse A, Bennett NM, Billing L, Sutton M, West N, Schaffner W, Talbot HK, Aquino C, George A, Budd A, Brammer L, Langley G, Hall AJ, Fry A. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, 1–30 March 2020. MMWR. Morbidity and Mortality Weekly Report. April 2020, s. 458–464. Dostupné online. DOI 10.15585/mmwr.mm6915e3. PMID 32298251. 
  • Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, Deng Y, Lin S. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. Journal of Medical Virology. April 2020, s. 1915–1921. DOI 10.1002/jmv.25889. PMID 32293753. 
  • HSIEH, Ying-Hen; TSAI, Chen-An; LIN, Chien-Yu; CHEN, Jin-Hua; KING, Chwan-Chuen; CHAO, Day-Yu; CHENG, Kuang-Fu. Asymptomatic ratio for seasonal H1N1 influenza infection among schoolchildren in Taiwan. S. 80. BMC Infectious Diseases [online]. 2014-12 [cit. 2020-10-28]. Roč. 14, čís. 1, s. 80. Dostupné online. DOI 10.1186/1471-2334-14-80. (anglicky) 
  • GRUBAUGH, Nathan D.; PETRONE, Mary E.; HOLMES, Edward C. We shouldn’t worry when a virus mutates during disease outbreaks. S. 529–530. Nature Microbiology [online]. 2020-04 [cit. 2020-10-28]. Roč. 5, čís. 4, s. 529–530. Dostupné online. DOI 10.1038/s41564-020-0690-4. (anglicky) 

doi.org

  • SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 2019-08-01, roč. 36, čís. 8, s. 1878–1905. Dostupné online [cit. 2020-11-18]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764. (anglicky) 
  • VAN DOREMALEN, Neeltje; BUSHMAKER, Trenton; MORRIS, Dylan H. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020-03-17, roč. 0, čís. 0, s. null. Dostupné online [cit. 2020-04-11]. ISSN 0028-4793. DOI 10.1056/NEJMc2004973. PMID 32182409. 
  • Yang W, Kandula S, Huynh M, Greene SK, Van Wye G, Li W, Chan HT, McGibbon E, Yeung A, Olson D, Fine A, Shaman J. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. The Lancet. Infectious Diseases. October 2020. Dostupné online. DOI 10.1016/s1473-3099(20)30769-6. PMID 33091374. 

elpais.com

  • ANSEDE, Manuel. Doscientos enfermos probarán un fármaco que ha bloqueado el coronavirus en minirriñones humanos. El País [online]. 2020-04-04 [cit. 2020-10-28]. Dostupné online. (španělsky) 

elsevier.com

linkinghub.elsevier.com

  • Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2021-02-XX, roč. 397, čís. 10274, s. 605–612. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00149-5. PMID 33545096. (anglicky) 
  • Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet. 2021-05-14, s. S0140673621008977. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00897-7. (anglicky) 
  • HORBY, Peter W; MAFHAM, Marion; BELL, Jennifer L. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2020-10-XX, roč. 396, čís. 10259, s. 1345–1352. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(20)32013-4. PMID 33031764. (anglicky) 
  • Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2021-05-01, roč. 397, čís. 10285, s. 1637–1645. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00676-0. PMID 33933206. (anglicky) 

reader.elsevier.com

  • WU, Canrong; LIU, Yang; YANG, Yueying; ZHANG, Peng; ZHONG, Wu; WANG, Yali; WANG, Qiqi. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. S. 766–788. Acta Pharmaceutica Sinica B [online]. 2020-02-18 [cit. 2020-10-28]. Roč. 10, čís. 5/2020, s. 766–788. Dostupné online. DOI 10.1016/j.apsb.2020.02.008. (anglicky) 

europa.eu

ecdc.europa.eu

ema.europa.eu

  • COVID-19 medicines - Authorised COVID-19 treatments. www.ema.europa.eu [online]. European Medicines Agency (EMA) [cit. 2024-08-15]. Dostupné online. (anglicky) 

fda.gov

fzone.cz

  • DVOŘÁČKOVÁ, Kristýna. Podle nové studie má britská mutace COVID-19 výrazně vyšší úmrtnost [online]. fzone.cz, 2021-03-11 [cit. 2021-07-23]. Dostupné online. 

globes.co.il

en.globes.co.il

google.cz

scholar.google.cz

  • [5] Irena Koutná, přehled publikovaných prací k 1.6.2021

gov.cz

covid.gov.cz

guidetopharmacology.org

blog.guidetopharmacology.org

  • GtoPdb pre-release ligands (2020.2). blog.guidetopharmacology.com [online]. 2020-03-13 [cit. 2020-10-28]. Dostupné online. (anglicky) 

guidetopharmacology.org

  • compound 15 [PMID: 32045236] [online]. guidetopharmacology.org [cit. 2020-10-28]. Dostupné online. (anglicky) 

harvard.edu

adsabs.harvard.edu

health.gov.au

  • Quarantine for coronavirus (COVID-19) [online]. [cit. 2020-09-25]. Dostupné online. 

health.org.uk

  • Emerging findings on the impact of COVID-19 on black and minority ethnic people [online]. [cit. 2020-06-10]. Dostupné online. 

healthline.com

heraldopenaccess.us

  • JAVIER C, Vázquez. Delirium In Severe Acute Respiratory Syndrome-Coronavirus-2 Infection: A Point Of View. S. 1–5. Clinical Immunology and Immunotherapy [online]. 2020-09-07 [cit. 2020-11-20]. Roč. 6, čís. 4, s. 1–5. Dostupné online. DOI 10.24966/CIIT-8844/1000039. (anglicky) 

hmri.org.au

  • What are the long-term symptoms of COVID-19? [online]. 4 August 2020 [cit. 2020-09-08]. Dostupné online. 

ibr-inc.com

  • Fc mediated effector functions [online]. iBR Advanced Bioanalytics [cit. 2020-12-27]. Dostupné online. (anglicky) 

icm-mhi.org

  • Colchicine reduces the risk of COVID-19-related complications [online]. icm-mhi.org, 2021-01-23 [cit. 2024-01-02]. Dostupné online. (anglicky) 

idnes.cz

  • LÁZŇOVSKÝ, Matouš. Univerzita Karlova představila nový test na covid-19. Převratný není. iDNES.cz [online]. MAFRA, 2020-09-09 [cit. 2020-10-28]. Dostupné online. 
  • Říkejme čínská chřipka místo COVID-19, napodobil Kalousek Trumpa. iDNES.cz [online]. MAFRA, 2020-03-21 [cit. 2020-05-05]. Dostupné online. 

iflscience.com

  • PALLISTER, Katy. COVID-19 Symptoms Take On Average Five Days To Show, Study Reveals. IFLScience [online]. 2020-03-10 [cit. 2020-03-25]. Dostupné online. (anglicky) 

ilmessaggero.it

  • Coronavirus, recidiva possibile: ipotesi infezione da un diverso ceppo del Covid-19. Il Messagero.it [online]. 29. února 2020 [cit. 2020-04-05]. Dostupné online. (italsky) 

independent.co.uk

  • How coronavirus deaths in the UK compare by race and ethnicity [online]. 9 June 2020 [cit. 2020-06-10]. Dostupné online. 

infekce.cz

  • BERAN, J. Použití inosin pranobex v prevenci a léčbě covid-19. Je k dispozici a nepoužívá se. – Proč?. infekce.cz [online]. 2020-04-02 [cit. 2020-12-27]. Dostupné v archivu pořízeném z originálu dne 2021-02-14. 

info.cz

  • KERLES, Marek. Proti koronaviru může pomoct čtvrt století stará pilulka z Ruska, potvrzuje virolog Růžek. Info.cz [online]. 2020-03-20 [cit. 2020-10-28]. Dostupné online. 

iniciativa-snih.cz

  • Týká se long covid i dětí? [online]. Iniciativa Sníh, 2021-05-28 [cit. 2021-07-23]. Dostupné online. 

iprima.cz

cnn.iprima.cz

irozhlas.cz

  • KUBIŠTOVÁ, Dominika. Účinný remdesivir, ústup od antimalarika plaquenil. Čím se léčí těžké případy koronaviru?. iROZHLAS [online]. Český rozhlas, 2020-09-12 [cit. 2020-09-12]. Dostupné online. 
  • Thajsko hlásí úspěch v léčbě koronaviru. Seniorku uzdravil koktejl léků na HIV a chřipku. iROZHLAS [online]. [[Český rozhlas|Český rozhlas]], 2020-02-03 [cit. 2020-02-11]. Dostupné online. 
  • MAGDOŇOVÁ, Jana. U dětí se po nákaze koronavirem může objevit vážný zánětlivý syndrom PIMS-TS. V Česku bylo 200 případů. iROZHLAS [online]. Český rozhlas, 18.3.2021 [cit. 7.1.2021]. Dostupné online. 
  • KUBIŠTOVÁ, Dominika; PRACHAŘ, Martin. Vše, co víme o koronaviru: nemění své chování, vytváří mikrosraženiny a chlad mu svědčí [online]. Český rozhlas, 2020-10-18 [cit. 2020-10-18]. Kapitola Mutace koronaviru: je nakažlivější?. Dostupné online. 

jamanetwork.com

  • THE WHO RAPID EVIDENCE APPRAISAL FOR COVID-19 THERAPIES (REACT) WORKING GROUP; STERNE, Jonathan A. C.; MURTHY, Srinivas. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020-10-06, roč. 324, čís. 13, s. 1330. Dostupné online [cit. 2021-05-16]. ISSN 0098-7484. DOI 10.1001/jama.2020.17023. PMID 32876694. (anglicky) 
  • VITALE, Josè; MUMOLI, Nicola; CLERICI, Pierangelo; DE PASCHALE, Massimo; EVANGELISTA, Isabella; CEI, Marco; MAZZONE, Antonino. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy. S. 1407. JAMA Internal Medicine [online]. 2021-10-01. Roč. 181, čís. 10, s. 1407. Dostupné online. DOI 10.1001/jamainternmed.2021.2959. (anglicky) 
  • Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatrics. April 2020, s. 882–889. Dostupné online. DOI 10.1001/jamapediatrics.2020.1467. PMID 32320004. 

jst.go.jp

jstage.jst.go.jp

  • GAO, Jianjun; TIAN, Zhenxue; YANG, Xu. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. S. 72–73. BioScience Trends [online]. 2020-02-29 [cit. 2020-10-28]. Roč. 14, čís. 1, s. 72–73. Dostupné online. ISSN 1881-7815. DOI 10.5582/bst.2020.01047. (anglicky) 

kebijakankesehatanindonesia.net

kff.org

  • COVID-19 Presents Significant Risks for American Indian and Alaska Native People [online]. 14 May 2020. Dostupné online. 
  • COVID-19 Presents Significant Risks for American Indian and Alaska Native People [online]. 14 May 2020. Dostupné online. 

lidovky.cz

  • PECHÁČKOVÁ, Alena. Expert popisuje správné větrání. Jak snížit riziko šíření covidu doma, v taxíku či místnostech bez oken. Lidovky.cz [online]. MAFRA, 2020-09-10 [cit. 2020-12-18]. Dostupné online. 

lji.org

  • First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development. lji.org [online]. 2020-05-14 [cit. 2020-12-28]. Dostupné online. (anglicky) 

mayoclinic.org

  • COVID-19 (coronavirus): Long-term effects [online]. 18 August 2020 [cit. 2020-09-08]. Dostupné online. 

medicalxpress.com

  • COVID transmission 1,000 times more likely from air vs. surfaces, says study. medicalxpress.com [online]. 2022-05-04 [cit. 2022-08-15]. Dostupné online. (anglicky) 
  • Ten reasons why the coronavirus is airborne (Deset důvodů proč se koronový virus přenáší vzduchem). Medicalxpress'', [1] (anglicky).
  • QUINN, Lauren. Global analysis suggests COVID-19 is seasonal. medicalxpress.com [online]. 2021-01-27 [cit. 2021-02-23]. Dostupné online. (anglicky) 
  • Simple oral hygiene could help reduce COVID-19 severity, says study. Medicalxpress, [2] (anglicky).
  • Unborn babies could contract COVID-19 says study, but it would be uncommon. medicalxpress.com [online]. 2021-11-19 [cit. 2022-01-09]. Dostupné online. (anglicky) 
  • Rapid immune response in children protects them from COVID-19, genetic study finds. medicalxpress.com [online]. 2021-12-22 [cit. 2022-01-08]. Dostupné online. (anglicky) 
  • New study may help explain why infants are less affected by COVID than adults. medicalxpress.com [online]. 2021-12-10 [cit. 2022-01-08]. Dostupné online. (anglicky) 
  • Smoking history tied to worse COVID-19 outcomes. medicalxpress.com [online]. 2021-01-26 [cit. 2021-02-23]. Dostupné online. (anglicky) 
  • Antimalarial drug no better than standard coronavirus care: study. medicalxpress.com [online]. 2020-03-25 [cit. 2020-10-27]. Dostupné online. (anglicky) 
  • SREEKUMAR, Lekshmy. Individual SARS-CoV-2 neutralizing antibody immunity lasts from days to decades. medicalxpress.com [online]. 2021-03-23 [cit. 2022-01-09]. Dostupné online. (anglicky) 
  • New study suggests two paths toward 'super immunity' to COVID-19. medicalxpress.com [online]. 2022-01-25 [cit. 2022-08-15]. Dostupné online. (anglicky) 
  • BRYANT, Vanessa; HOLMES, Alex; IRVING, Louis. The mystery of 'long COVID': What we know so far. medicalxpress.com [online]. 2021-06-07 [cit. 2022-01-08]. Dostupné online. (anglicky) 
  • Researchers confirm link between testing positive for COVID-19 and fatigue and sleep problems. medicalxpress.com [online]. 2021-11-16 [cit. 2022-01-08]. Dostupné online. (anglicky) 
  • Post-COVID syndrome severely damages children's hearts. medicalxpress.com [online]. [cit. 2020-09-07]. Dostupné online. (anglicky) 
  • Can the coronavirus really live for 3 days on plastic? Yes, but it's complicated.. medicalxpress.com [online]. [cit. 2020-04-11]. Dostupné online. (anglicky) 
  • FERNANDEZ, Sonia. Researchers model spread of SARS-CoV-2 virus in various temperatures and relative humidities. medicalxpress.com [online]. 2020-10-14 [cit. 2020-10-28]. Dostupné online. (anglicky) 
  • Coronavirus takes aim at fat cells, study shows. medicalxpress.com [online]. 2021-12-09 [cit. 2022-01-09]. Dostupné online. (anglicky) 

medium.com

  • MODI, Chirag. How deadly is COVID-19? Data Science offers answers from Italy mortality data.. Medium [online]. 2020-04-21 [cit. 2021-01-20]. Dostupné online. (anglicky) 

medrxiv.org

  • COOMES, Eric Anthony; HAGHBAYAN, Hourmazd. Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis. S. 2020.03.30.20048058. medRxiv [online]. 2020-04-03 [cit. 2020-10-27]. S. 2020.03.30.20048058. Dostupné online. DOI 10.1101/2020.03.30.20048058. (anglicky) 
  • TAHVILDARI, Azin; ARBABI, Mahta; FARSI, Yeganeh; JAMSHIDI, Parnian; HASANZADEH, Saba; CALCAGNO, Tess Moore; NASIRI, Mohammad Javad. Clinical features, Diagnosis, and Treatment of COVID-19: A systematic review of case reports and case series. medRxiv preprint [online]. 2020-04-03 [cit. 2020-10-28]. Dostupné online. DOI 10.1101/2020.03.28.20046151. (anglicky) 
  • MILLER, Aaron; REANDELAR, Mac Josh; FASCIGLIONE, Kimberly; ROUMENOVA, Violeta; LI, Yan; OTAZU, Gonzalo H. Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. medRxiv [online]. 2020-09-14 [cit. 2020-10-28]. Dostupné online. DOI 10.1101/2020.03.24.20042937. (anglicky) 
  • PULLIAM, Juliet R.C.; VAN SCHALKWYK, Cari; GOVENDER, Nevashan; VON GOTTBERG, Anne; COHEN, Cheryl; GROOME, Michelle J.; DUSHOFF, Jonathan. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. preprint [online]. 2021-11-11. Dostupné online. DOI 10.1101/2021.11.11.21266068. (anglicky) 

merck.com

  • Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study. merck.com [online]. 2021-10-01 [cit. 2024-01-02]. Dostupné online. (anglicky) 

mit.edu

news.mit.edu

mzcr.cz

onemocneni-aktualne.mzcr.cz

  • COVID-19 | Onemocnění Aktuálně MZČR. onemocneni-aktualne.mzcr.cz [online]. Ministerstvo zdravotnictví ČR [cit. 2021-01-20]. Dostupné online. 

nature.com

  • SWADLING, Leo; DINIZ, Mariana O.; SCHMIDT, Nathalie M.; AMIN, Oliver E.; CHANDRAN, Aneesh; SHAW, Emily; PADE, Corinna. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. S. 110–117. Nature [online]. 2022-01-06. Roč. 601, čís. 7891, s. 110–117. Dostupné online. DOI 10.1038/s41586-021-04186-8. (anglicky) 
  • PAIRO-CASTINEIRA, Erola; CLOHISEY, Sara; KLARIC, Lucija; BRETHERICK, Andrew D.; RAWLIK, Konrad; PASKO, Dorota; WALKER, Susan. Genetic mechanisms of critical illness in Covid-19. Nature [online]. 2020-12-11 [cit. 2020-12-27]. Dostupné online. DOI 10.1038/s41586-020-03065-y. (anglicky) 
  • WANG, Manli; CAO, Ruiyuan; ZHANG, Leike; YANG, Xinglou; LIU, Jia; XU, Mingyue; SHI, Zhengli. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. S. 269–271. Cell Research [online]. 2020-03 [cit. 2020-10-27]. Roč. 30, čís. 3, s. 269–271. Dostupné online. DOI 10.1038/s41422-020-0282-0. (anglicky) 
  • AXFORS, Cathrine; SCHMITT, Andreas M.; JANIAUD, Perrine; VAN’T HOOFT, Janneke; ABD-ELSALAM, Sherief; ABDO, Ehab F.; ABELLA, Benjamin S. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. S. 2349. Nature Communications [online]. 2021-04-15. Roč. 12, čís. 1, s. 2349. Dostupné online. DOI 10.1038/s41467-021-22446-z. (anglicky) 
  • COX, Robert M.; WOLF, Josef D.; PLEMPER, Richard K. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. S. 11–18. Nature Microbiology [online]. 2021-01 [cit. 2021-02-23]. Roč. 6, čís. 1, s. 11–18. Dostupné online. DOI 10.1038/s41564-020-00835-2. (anglicky) 
  • BRADLEY, Conor A. CD24 — a novel ‘don’t eat me’ signal. S. 541. Nature Reviews Cancer [online]. 2019-10. Roč. 19, čís. 10, s. 541. Dostupné online. DOI 10.1038/s41568-019-0193-x. (anglicky) 
  • BARKAL, Amira A.; BREWER, Rachel E.; MARKOVIC, Maxim; KOWARSKY, Mark; BARKAL, Sammy A.; ZARO, Balyn W.; KRISHNAN, Venkatesh. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. S. 392–396. Nature [online]. 2019-08 [cit. 2021-02-23]. Roč. 572, čís. 7769, s. 392–396. Dostupné online. DOI 10.1038/s41586-019-1456-0. (anglicky) 
  • LE BERT, Nina; TAN, Anthony T.; KUNASEGARAN, Kamini; THAM, Christine Y. L.; HAFEZI, Morteza; CHIA, Adeline; CHNG, Melissa Hui Yen. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. S. 457–462. Nature [online]. 2020-08-20. Roč. 584, čís. 7821, s. 457–462. Dostupné online. DOI 10.1038/s41586-020-2550-z. (anglicky) 
  • GAEBLER, Christian; WANG, Zijun; LORENZI, Julio C. C.; MUECKSCH, Frauke; FINKIN, Shlomo; TOKUYAMA, Minami; CHO, Alice. Evolution of antibody immunity to SARS-CoV-2. Nature [online]. 2021-01-18 [cit. 2021-02-23]. Dostupné online. DOI 10.1038/s41586-021-03207-w. (anglicky) 
  • KHAMSI, Roxanne. Rogue antibodies could be driving severe COVID-19. S. 29–31. Nature [online]. 2021-02-04. Roč. 590, čís. 7844, s. 29–31. Dostupné online. DOI 10.1038/d41586-021-00149-1. (anglicky) 
  • MULLARD, Asher. How COVID vaccines are being divvied up around the world. Canada leads the pack in terms of doses secured per capita.. Nature. 30 November 2020. Dostupné online [cit. 11 December 2020]. DOI 10.1038/d41586-020-03370-6. PMID 33257891. S2CID 227246811. 
  • Mallapaty S. How deadly is the coronavirus? Scientists are close to an answer. Nature. 16 June 2020, s. 467–468. Dostupné online. DOI 10.1038/d41586-020-01738-2. PMID 32546810. S2CID 219726496. Bibcode 2020Natur.582..467M. 
  • GRUBAUGH, Nathan D.; PETRONE, Mary E.; HOLMES, Edward C. We shouldn’t worry when a virus mutates during disease outbreaks. S. 529–530. Nature Microbiology [online]. 2020-04 [cit. 2020-10-28]. Roč. 5, čís. 4, s. 529–530. Dostupné online. DOI 10.1038/s41564-020-0690-4. (anglicky) 

nejm.org

nih.gov

ncbi.nlm.nih.gov

  • Ye Q, Wang B, Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. The Journal of Infection. June 2020, s. 607–613. ISSN 0163-4453. DOI 10.1016/j.jinf.2020.03.037. PMID 32283152. 
  • Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, Guaraldi G, Mussini C, Gudiol C, Pujol M, Bandera A, Scudeller L, Paul M, Kaiser L, Leibovici L. Long-term consequences of COVID-19: research needs. The Lancet. Infectious Diseases. September 2020, s. 1115–1117. DOI 10.1016/S1473-3099(20)30701-5. PMID 32888409. 
  • SENDER, Ron; BAR-ON, Yinon M.; GLEIZER, Shmuel; BERNSHTEIN, Biana; FLAMHOLZ, Avi; PHILLIPS, Rob; MILO, Ron. The total number and mass of SARS-CoV-2 virions. Proceedings of the National Academy of Sciences [online]. 2021-06-22. Roč. 118, čís. 25. Dostupné online. DOI 10.1073/pnas.2024815118. PMID 34083352. (anglicky) 
  • HAN, Chaoqun; DUAN, Caihan; ZHANG, Shengyan; SPIEGEL, Brennan; SHI, Huiying; WANG, Weijun; ZHANG, Lei. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes. S. 916–923. American Journal of Gastroenterology [online]. 2020-06 [cit. 2021-01-05]. Roč. 115, čís. 6, s. 916–923. Dostupné online. DOI 10.14309/ajg.0000000000000664. PMID 32301761. (anglicky) 
  • KLOK, F.A.; KRUIP, M.J.H.A.; VAN DER MEER, N.J.M.; ARBOUS, M.S.; GOMMERS, D.A.M.P.J.; KANT, K.M.; KAPTEIN, F.H.J. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. S. 145–147. Thrombosis Research [online]. 2020-04-10 [cit. 2020-10-28]. Roč. 191, čís. 7/2020, s. 145–147. Dostupné online. DOI 10.1016/j.thromres.2020.04.013. PMID 32291094. (anglicky) 
  • KORY, Pierre; MEDURI, Gianfranco Umberto; VARON, Joseph; IGLESIAS, Jose; MARIK, Paul E. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. S. e299–e318. American Journal of Therapeutics [online]. 2021-05. Roč. 28, čís. 3, s. e299–e318. Dostupné online. DOI 10.1097/MJT.0000000000001377. PMID 34375047. (anglicky) 
  • GORDON, Calvin J.; TCHESNOKOV, Egor P.; FENG, Joy Y.; PORTER, Danielle P.; GÖTTE, Matthias. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. S. 4773–4779. Journal of Biological Chemistry [online]. 2020-04-10 [cit. 2020-10-27]. Roč. 295, čís. 15, s. 4773–4779. Dostupné online. DOI 10.1074/jbc.AC120.013056. PMID 32094225. (anglicky) 
  • HENNIGAN, Stephanie; KAVANAUGH, Arthur. Interleukin-6 inhibitors in the treatment of rheumatoid arthritis. S. 767–775. Therapeutics and Clinical Risk Management [online]. 2008-08-08 [cit. 2020-10-27]. Roč. 2008, čís. August 4(4), s. 767–775. Dostupné online. DOI 10.2147/tcrm.s3470. PMID 19209259. (anglicky) 
  • FREITAS, Raquel Filipa; BASTO, Afonso; ALMEIDA, Silvia C.P.; SANTOS, Rita F.; GONÇALVES, Carine M.; CORRIA-OSORIO, Jesus; CARVALHO, Tânia. Modulation of CD4 T cell function via CD6-targeting. S. 427–435. EBioMedicine [online]. 2019-09 [cit. 2020-10-27]. Roč. 47, s. 427–435. Dostupné online. DOI 10.1016/j.ebiom.2019.08.008. PMID 31481324. (anglicky) 
  • CASCELLA, Marco; RAJNIK, Michael; CUOMO, Arturo; DULEBOHN, Scott C.; DI NAPOLI, Raffaela. Features, Evaluation, and Treatment of Coronavirus. StatPearls [online]. National Center for Biotechnology Information, 2020-03-20 [cit. 2020-10-28]. Dostupné online. PMID 32150360. (anglicky) 
  • YAMAMOTO, Mizuki; MATSUYAMA, Shutoku; LI, Xiao; TAKEDA, Makoto; KAWAGUCHI, Yasushi; INOUE, Jun-ichiro; MATSUDA, Zene. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. S. 6532–6539. Antimicrobial Agents and Chemotherapy [online]. 2016-10-21 [cit. 2020-10-28]. Roč. 60, čís. 11, s. 6532–6539. Dostupné online. DOI 10.1128/AAC.01043-16. PMID 27550352. (anglicky) 
  • CHEN, Yu Wai; YIU, Chin-Pang Bennu; WONG, Kwok-Yin. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. S. 129. F1000Research [online]. 2020-04-09 [cit. 2020-10-28]. Roč. 9, s. 129. DOI 10.12688/f1000research.22457.2. PMID 32194944. (anglicky) 
  • NGUYEN, Kim; DERSNAH, Graham D.; AHLAWAT, Rajni. Famotidine. StatPearls [online]. StatPearls Publishing, 2019-10-03 [cit. 2020-10-28]. Dostupné online. (anglicky) 
  • ROSSIGNOL, Jean-François. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. S. 227–230. Journal of Infection and Public Health [online]. 2016-05 [cit. 2020-10-28]. Roč. 9, čís. 3, s. 227–230. Dostupné online. DOI 10.1016/j.jiph.2016.04.001. PMID 27095301. (anglicky) 
  • SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 2019-08-01, roč. 36, čís. 8, s. 1878–1905. Dostupné online [cit. 2020-11-18]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764. (anglicky) 
  • Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2021-02-XX, roč. 397, čís. 10274, s. 605–612. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00149-5. PMID 33545096. (anglicky) 
  • THE RECOVERY COLLABORATIVE GROUP. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2020-11-19, roč. 383, čís. 21, s. 2030–2040. Dostupné online [cit. 2021-05-16]. ISSN 0028-4793. DOI 10.1056/NEJMoa2022926. PMID 33031652. (anglicky) 
  • HORBY, Peter W; MAFHAM, Marion; BELL, Jennifer L. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2020-10-XX, roč. 396, čís. 10259, s. 1345–1352. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(20)32013-4. PMID 33031764. (anglicky) 
  • THE RECOVERY COLLABORATIVE GROUP. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2021-02-25, roč. 384, čís. 8, s. 693–704. Dostupné online [cit. 2021-05-16]. ISSN 0028-4793. DOI 10.1056/NEJMoa2021436. PMID 32678530. (anglicky) 
  • THE WHO RAPID EVIDENCE APPRAISAL FOR COVID-19 THERAPIES (REACT) WORKING GROUP; STERNE, Jonathan A. C.; MURTHY, Srinivas. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020-10-06, roč. 324, čís. 13, s. 1330. Dostupné online [cit. 2021-05-16]. ISSN 0098-7484. DOI 10.1001/jama.2020.17023. PMID 32876694. (anglicky) 
  • Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2021-05-01, roč. 397, čís. 10285, s. 1637–1645. Dostupné online [cit. 2021-05-16]. DOI 10.1016/S0140-6736(21)00676-0. PMID 33933206. (anglicky) 
  • ZHANG, Mei-Yun; CHOUDHRY, Vidita; XIAO, Xiaodong; DIMITROV, Dimiter S. Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS. S. 151–156. Current Opinion in Molecular Therapeutics [online]. 2005-04 [cit. 2020-10-28]. Roč. 7, čís. 2, s. 151–156. Dostupné online. ISSN 1464-8431. PMID 15844623. 
  • DAN, Jennifer M.; MATEUS, Jose; KATO, Yu; HASTIE, Kathryn M.; YU, Esther Dawen; FALITI, Caterina E.; GRIFONI, Alba. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. S. eabf4063. Science [online]. [cit. 2021-05-08]. Roč. 371, čís. 6529, s. eabf4063. Dostupné online. DOI 10.1126/science.abf4063. PMID 33408181. (anglicky) 
  • DAVIDO, Benjamin; SEANG, Sophie; TUBIANA, Roland. Post–COVID-19 chronic symptoms: a postinfectious entity?. Clinical Microbiology and Infection. 2020-07-23. PMID: 32712242 PMCID: PMC7376333. Dostupné online [cit. 2020-09-07]. ISSN 1198-743X. DOI 10.1016/j.cmi.2020.07.028. PMID 32712242. 
  • MULLARD, Asher. How COVID vaccines are being divvied up around the world. Canada leads the pack in terms of doses secured per capita.. Nature. 30 November 2020. Dostupné online [cit. 11 December 2020]. DOI 10.1038/d41586-020-03370-6. PMID 33257891. S2CID 227246811. 
  • SO, Anthony D; WOO, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. December 2020, s. m4750. ISSN 1756-1833. DOI 10.1136/bmj.m4750. PMID 33323376. 
  • VAN DOREMALEN, Neeltje; BUSHMAKER, Trenton; MORRIS, Dylan H. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020-03-17, roč. 0, čís. 0, s. null. Dostupné online [cit. 2020-04-11]. ISSN 0028-4793. DOI 10.1056/NEJMc2004973. PMID 32182409. 
  • Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatrics. April 2020, s. 882–889. Dostupné online. DOI 10.1001/jamapediatrics.2020.1467. PMID 32320004. 
  • Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z, Xiang Y, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S, Wong GW. SARS-CoV-2 Infection in Children. The New England Journal of Medicine. Massachusetts Medical Society, April 2020, s. 1663–1665. DOI 10.1056/nejmc2005073. PMID 32187458. 
  • Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. June 2020, s. e20200702. DOI 10.1542/peds.2020-0702. PMID 32179660. S2CID 219118986. 
  • Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. The Lancet. Global Health. May 2020, s. e641–e642. Dostupné online. DOI 10.1016/S2214-109X(20)30110-8. PMID 32199072. 
  • Mallapaty S. How deadly is the coronavirus? Scientists are close to an answer. Nature. 16 June 2020, s. 467–468. Dostupné online. DOI 10.1038/d41586-020-01738-2. PMID 32546810. S2CID 219726496. Bibcode 2020Natur.582..467M. 
  • Alwan N, Burgess R, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman L, Greenhalgh T, Gurdasani D, Hamdy A, Hanage W, Hodcroft E, Hyde Z, Kellam P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar D, Swanton C, Walensky R, Yamey G, Ziauddeen H. Scientific consensus on the COVID-19 pandemic: we need to act now. The Lancet. 31 October 2020, s. E71–E72. DOI 10.1016/S0140-6736(20)32153-X. PMID 33069277. 
  • Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. International Journal of Infectious Diseases. December 2020, s. 138–148. DOI 10.1016/j.ijid.2020.09.1464. PMID 33007452. 
  • Levin A, Hanage W, Owusu-Boaitey N, Cochran K, Walsh S, Meyerowitz-Katz G. Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications. European Journal of Epidemiology. December 2020, s. 1123–1138. DOI 10.1007/s10654-020-00698-1. PMID 33289900. 
  • Yang W, Kandula S, Huynh M, Greene SK, Van Wye G, Li W, Chan HT, McGibbon E, Yeung A, Olson D, Fine A, Shaman J. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. The Lancet. Infectious Diseases. October 2020. Dostupné online. DOI 10.1016/s1473-3099(20)30769-6. PMID 33091374. 
  • Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. February 2020, s. 507–513. DOI 10.1016/S0140-6736(20)30211-7. PMID 32007143. 
  • Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. March 2020, s. 846–848. DOI 10.1016/S0140-6736(20)30526-2. PMID 32151325. 
  • EPIDEMIOLOGY WORKING GROUP FOR NCIP EPIDEMIC RESPONSE, Chinese Center for Disease Control Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. February 2020, s. 145–151. Dostupné online. DOI 10.3760/cma.j.issn.0254-6450.2020.02.003. PMID 32064853. S2CID 211133882. (čamorsky) 
  • Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. Journal of Clinical Virology. June 2020, s. 104371. DOI 10.1016/j.jcv.2020.104371. PMID 32315817. 
  • Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. The Journal of Infection. June 2020, s. 656–665. DOI 10.1016/j.jinf.2020.03.041. PMID 32283155. 
  • Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clinical Immunology. June 2020, s. 108427. DOI 10.1016/j.clim.2020.108427. PMID 32325252. S2CID 216028003. 
  • Dorn AV, Cooney RE, Sabin ML. COVID-19 exacerbating inequalities in the US. Lancet. April 2020, s. 1243–1244. DOI 10.1016/S0140-6736(20)30893-X. PMID 32305087. 
  • Adams ML, Katz DL, Grandpre J. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States. Emerging Infectious Diseases. April 2020, s. 1831–1833. DOI 10.3201/eid2608.200679. PMID 32324118. 
  • Laurencin CT, McClinton A. The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities. Journal of Racial and Ethnic Health Disparities. April 2020, s. 398–402. DOI 10.1007/s40615-020-00756-0. PMID 32306369. 
  • Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Yousey-Hindes K, Niccolai L, Anderson EJ, Openo KP, Weigel A, Monroe ML, Ryan P, Henderson J, Kim S, Como-Sabetti K, Lynfield R, Sosin D, Torres S, Muse A, Bennett NM, Billing L, Sutton M, West N, Schaffner W, Talbot HK, Aquino C, George A, Budd A, Brammer L, Langley G, Hall AJ, Fry A. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, 1–30 March 2020. MMWR. Morbidity and Mortality Weekly Report. April 2020, s. 458–464. Dostupné online. DOI 10.15585/mmwr.mm6915e3. PMID 32298251. 
  • Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, Deng Y, Lin S. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. Journal of Medical Virology. April 2020, s. 1915–1921. DOI 10.1002/jmv.25889. PMID 32293753. 

covid19treatmentguidelines.nih.gov

  • Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [online]. National Institutes of Health, rev. 2021-02-11 [cit. 2021-03-14]. Kapitola Ivermectin. Dostupné v archivu pořízeném dne 2021-01-19. (anglicky) 

aidsinfo.nih.gov

nccih.nih.gov

  • In the News: Coronavirus and “Alternative” Treatments. National Center for Complementary and Integrative Health [online]. [cit. 2020-02-16]. Dostupné online. 

pubmed.ncbi.nlm.nih.gov

  • ZHANG, Mei-Yun; CHOUDHRY, Vidita; XIAO, Xiaodong; DIMITROV, Dimiter S. Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS. S. 151–156. Current Opinion in Molecular Therapeutics [online]. 2005-04 [cit. 2020-10-28]. Roč. 7, čís. 2, s. 151–156. Dostupné online. ISSN 1464-8431. PMID 15844623. 

novinky.cz

  • Koronavirus se může ohlásit ztrátou čichu a chuti. Novinky.cz [online]. Borgis, 2020-03-23 [cit. 2020-03-23]. Dostupné online. 
  • Lék sotrovimab zabírá na všechny mutace včetně omikronu. Novinky.cz [online]. Borgis [cit. 2021-12-08]. Dostupné online. 
  • BAZALOVÁ, Angelika. Vědkyně Koutná: Paměťová imunita chrání po prodělání covidu nejméně rok. Novinky.cz [online]. Borgis, 2020-12-23 [cit. 2021-01-10]. Dostupné online. 
  • DRAKE, Daniel. Covid-19 se stane endemickým, nebo zcela zmizí, předpovídá izraelský odborník. Novinky.cz [online]. Borgis, 7.1.2022 [cit. 7.1.2022]. Dostupné online. 

nyc.gov

www1.nyc.gov

  • COVID-19: Data [online]. City of New York. Dostupné online. 

nytimes.com

  • THOMAS, Katie; WEILAND, Noah. Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval. The New York Times [online]. 2020-11-10 [cit. 2020-12-27]. Dostupné online. ISSN 0362-4331. (anglicky) 
  • MCNEIL JR., Donald G. The Pandemic's Big Mystery: How Deadly Is the Coronavirus? – Even with more than 500,000 dead worldwide, scientists are struggling to learn how often the virus kills. Here's why. The New York Times. 4 July 2020. Dostupné online [cit. 6 July 2020]. 
  • RABIN, Roni Caryn. In Italy, Coronavirus Takes a Higher Toll on Men. The New York Times. 20 March 2020. Dostupné online [cit. 7 April 2020]. 
  • GUPTA, Alisha Haridasani. Does Covid-19 Hit Women and Men Differently? U.S. Isn't Keeping Track. The New York Times. 3 April 2020. Dostupné online [cit. 7 April 2020]. 
  • KRISTOF, Nicholas; THOMPSON, Stuart A. Opinion | Trump Wants to ‘Reopen America.’ Here’s What Happens if We Do.. The New York Times. 2020-03-25. Dostupné online [cit. 2020-03-26]. ISSN 0362-4331. (anglicky) 

osel.cz

  • KREMLÍK, Vítězslav. Covid zvýšil roční úmrtnost... na míru dříve běžnou. osel.cz [online]. 2021-10-08 [cit. 2022-01-08]. Dostupné online. 
  • MIHULKA, Stanislav. Proč je nutné mít zavřené školy. osel.cz [online]. 2020-10-29 [cit. 2020-11-20]. Dostupné online. 
  • PAZDERA, Josef. Mohla by krev těch, kteří přestáli COVID-19, zachraňovat životy?. OSEL.CZ [online]. 2020-03-28 [cit. 2020-09-12]. Dostupné online. 
  • PAZDERA, Josef. Sluníčko zničí koronavirus rychle. www.osel.cz [online]. [cit. 2020-04-26]. Dostupné online. 

ourworldindata.org

  • Coronavirus (COVID-19) Vaccinations - Statistics and Research - Our World in Data [online]. Global Change Data Lab [cit. 2021-02-14]. Dostupné online. 
  • RITCHIE, Hannah; ROSER, Max. What do we know about the risk of dying from COVID-19? [online]. Redakce Chivers Tom. 25 March 2020 [cit. 2020-03-28]. Dostupné v archivu pořízeném z originálu dne 28 March 2020. 
  • What do we know about the risk of dying from COVID-19? [online]. [cit. 2020-03-28]. Dostupné v archivu pořízeném z originálu dne 28 March 2020. 

ox.ac.uk

  • Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. www.ox.ac.uk [online]. Oxfordská univerzita, 2020-06-16 [cit. 2020-10-28]. Dostupné online. (anglicky) 

pharmaceutical-technology.com

  • Favilavir approved as experimental coronavirus drug. www.pharmaceutical-technology.com [online]. 2020-02-21 [cit. 2020-03-15]. Dostupné online. 

plos.org

journals.plos.org

  • GRANT, Michael C.; GEOGHEGAN, Luke; ARBYN, Marc; MOHAMMED, Zakaria; MCGUINNESS, Luke; CLARKE, Emily L. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE [online]. 2020-06-23 [cit. 2020-09-12]. Dostupné online. DOI 10.1371/journal.pone.0234765. (anglicky) 

racgp.org.au

www1.racgp.org.au

  • What are the long-term health risks following COVID-19? [online]. Royal Australian College of General Practitioners (RACGP), 24 June 2020 [cit. 2020-09-08]. Dostupné online. 

recoverytrial.net

regeneron.com

investor.regeneron.com

  • Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COV™ (casirivimab with imdevimab) [online]. investor.regeneron.com, 2021-04-12 [cit. 2024-01-02]. Dostupné online. (anglicky) 

remedia.cz

  • SALAJKA, František. Ciclesonidum [online]. remedia.cz, 2005-07 [cit. 2020-10-28]. Dostupné online. 
  • Inosin pranobex, klinickou praxí ověřený účinný imunomodulátor; možné mechanismy působení. remedia.cz [online]. 2018-08 [cit. 2020-12-27]. Roč. 2018, čís. 04. Dostupné online. 

reuters.com

  • Study at Ischgl ski resort finds lasting coronavirus immunity. Reuters, [3], 18. února 2021 (anglicky).

ria.ru

  • В Таиланде женщина повторно заразилась коронавирусом. RIA Novosti [online]. 2020-04-09 [cit. 2020-04-09]. Dostupné online. (rusky) 

rt.com

  • MACDONALD, Bryan. China tests Russian anti-viral drug which might treat coronavirus as Moscow warns of possible 'mass outbreak'. RT International [online]. 2020-02-04 [cit. 2020-10-28]. Dostupné online. (anglicky) 

sciencealert.com

  • NAFTULIN, Julia. Wuhan Coronavirus Can Be Infectious Before People Show Symptoms, Official Claims. sciencealert.com [online]. 2020-01-26 [cit. 2020-10-28]. Dostupné online. (anglicky) 
  • WOODWARD, Aylin. New Evidence Suggests COVID-19 Immunity Can Last 6 to 8 Months After Infection. sciencealert.com [online]. 2020-11-29 [cit. 2020-12-28]. Dostupné online. (anglicky) 

sciencedaily.com

  • The ancient Neanderthal hand in severe COVID-19. sciencedaily.com [online]. 2020-09-30 [cit. 2024-01-02]. Dostupné online. (anglicky) 

sciencedirect.com

  • SNIJDER, Eric J.; BREDENBEEK, Peter J.; DOBBE, Jessika C.; THIEL, Volker; ZIEBUHR, John; POON, Leo L.M.; GUAN, Yi. Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. S. 991–1004. Journal of Molecular Biology [online]. 2003-08 [cit. 2020-10-30]. Roč. 331, čís. 5, s. 991–1004. Dostupné online. DOI 10.1016/S0022-2836(03)00865-9. (anglicky) 
  • CALY, Leon; DRUCE, Julian D.; CATTON, Mike G.; JANS, David A.; WAGSTAFF, Kylie M. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. S. 104787. Antiviral Research [online]. 2020-04-03 [cit. 2020-10-28]. Roč. 178, čís. 6/2020, s. 104787. Dostupné online. DOI 10.1016/j.antiviral.2020.104787. (anglicky) 
  • IKEZAKI, Hiroaki; NOMURA, Hideyuki; SHIMONO, Nobuyuki. Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers. Journal of Infection and Chemotherapy. 2022-06-01, roč. 28, čís. 6, s. 802–805. Dostupné online [cit. 2022-07-17]. ISSN 1341-321X. DOI 10.1016/j.jiac.2022.02.024. (anglicky) 
  • MENEBO, Mesay Moges. Temperature and precipitation associate with Covid-19 new daily cases: A correlation study between weather and Covid-19 pandemic in Oslo, Norway. S. 139659. Science of The Total Environment [online]. 2020-10 [cit. 2020-10-28]. Roč. 737, s. 139659. Dostupné online. DOI 10.1016/j.scitotenv.2020.139659. (anglicky) 

sciencemag.org

  • BORRELL, Brendan. New York clinical trial quietly tests heartburn remedy against coronavirus. Science [online]. 2020-04-26 [cit. 2020-10-28]. Dostupné online. (anglicky) 

scientificamerican.com

  • BARBER, Carolyn. COVID-19 Can Wreck Your Heart, Even if You Haven’t Had Any Symptoms. Scientific American [online]. [cit. 2020-09-07]. Dostupné online. (anglicky) 

scmp.com

  • MA, Josephine; LEW, Linda; JEONG-HO, Lee. A third of virus cases may be ‘silent carriers’, classified data suggests. South China Morning Post [online]. 2020-03-22 [cit. 2020-10-28]. Dostupné online. (anglicky) 

seattletimes.com

  • CUNNINGHAM, Erin; HASSAN, Jennifer. Most coronavirus deaths occurred in countries where majority of adults are overweight. The Seattle Times [online]. 2021-03-04 [cit. 2021-05-08]. Dostupné online. (anglicky) 

semanticscholar.org

api.semanticscholar.org

semanticscholar.org

  • HAJIALI, A.; PIRUMYAN, G. Efficiency of Ozonation Disinfection in a Domestic Wastewater Treatment for Removing Existing Infectious Bacteria and Viruses and a Comparison with Chlorine Disinfection. www.semanticscholar.org [online]. 2018 [cit. 2020-10-28]. Dostupné online. (anglicky) 

seznamzpravy.cz

  • KUČEROVÁ, Daniela. Dobrá zpráva pro vyléčené z covidu. Imunita drží měsíce. Má to však své ale. Seznam Zprávy [online]. 2021-01-14 [cit. 2021-05-08]. Dostupné online. 
  • PŘÁDOVÁ, Daniela. Šest otázek k vakcíně na covid: Proč se nebudují očkovací centra? A co děti?. Seznam Zprávy [online]. Seznam.cz, 2020-12-17 [cit. 2020-12-17]. Dostupné online. 

springer.com

link.springer.com

  • CHEN, Chen; ZHOU, Yiwu; WANG, Dao Wen. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. S. 230–232. Herz [online]. 2020-03-05 [cit. 2020-10-28]. Roč. 45, čís. 3, s. 230–232. Dostupné online. DOI 10.1007/s00059-020-04909-z. (anglicky) 
  • HSIEH, Ying-Hen; TSAI, Chen-An; LIN, Chien-Yu; CHEN, Jin-Hua; KING, Chwan-Chuen; CHAO, Day-Yu; CHENG, Kuang-Fu. Asymptomatic ratio for seasonal H1N1 influenza infection among schoolchildren in Taiwan. S. 80. BMC Infectious Diseases [online]. 2014-12 [cit. 2020-10-28]. Roč. 14, čís. 1, s. 80. Dostupné online. DOI 10.1186/1471-2334-14-80. (anglicky) 

ssrn.com

papers.ssrn.com

  • WILSON, Linus. SARS-CoV-2, COVID-19, Infection Fatality Rate (IFR) Implied by the Serology, Antibody, Testing in New York City. SSRN Electronic Journal [online]. 2020-05. Dostupné online. DOI 10.2139/ssrn.3590771. (anglicky) 

statnews.com

  • SANTIAGO, Jahleah. A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines [online]. 19 December 2020 [cit. 2020-12-24]. Dostupné online. 

sukl.cz

swissinfo.ch

  • KUCHLER, Hannah; MANCINI, Donato Paolo. WHO and Roche launch trials of potential coronavirus treatments. swissinfo.ch [online]. 2020-03-20 [cit. 2020-10-28]. Dostupné online. (anglicky) 

techfocus.cz

  • POKORNÝ, Martin. Čeští vědci testují novou protilátku proti covidu-19, je vhodná i k léčbě a brání viru mutovat. techfocus.cz [online]. 2021-01-26 [cit. 2021-05-08]. Dostupné online. 

thailandmedical.news

  • NEWS, Thailand Medical. Ozone Can Be Used To Destroy The New Coronavirus And Disinfect Areas – Thailand Medical News. Ozone Can Be Used To Destroy The New Coronavirus And Disinfect Areas – Thailand Medical News [online]. [cit. 2020-04-11]. Dostupné online. (anglicky) 

theadvocate.com

  • DEROBERTIS, Jacqueline. People who use drugs are more vulnerable to coronavirus. Here's what clinics are doing to help. [online]. 3 May 2020 [cit. 2020-05-04]. Dostupné online. 

theguardian.com

  • Coronavirus: Japanese woman tests positive for second time. The Guardian [online]. 27. února 2020 [cit. 2020-04-05]. Dostupné online. (anglicky) 
  • BEAUMONT, Peter. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 18 November 2020. Dostupné online [cit. 26 December 2020]. ISSN 0261-3077. 

thelancet.com

  • RICHARDSON, Peter; GRIFFIN, Ivan; TUCKER, Catherine; SMITH, Dan; OECHSLE, Olly; PHELAN, Anne; RAWLING, Michael. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. S. 30–e31. The Lancet [online]. 2020-02-15 [cit. 2020-10-28]. Roč. 395, čís. 10223, s. 30–e31. Dostupné online. DOI 10.1016/S0140-6736(20)30304-4. (anglicky) 
  • Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. The Lancet, [4] (anglicky).
  • TOWNSEND, Jeffrey P; HASSLER, Hayley B; WANG, Zheng; MIURA, Sayaka; SINGH, Jaiveer; KUMAR, Sudhir; RUDDLE, Nancy H. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. S. e666–e675. The Lancet Microbe [online]. 2021-12. Roč. 2, čís. 12, s. e666–e675. Dostupné online. DOI 10.1016/S2666-5247(21)00219-6. (anglicky) 
  • Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. The Lancet. Global Health. May 2020, s. e641–e642. Dostupné online. DOI 10.1016/S2214-109X(20)30110-8. PMID 32199072. 

thoughteconomics.com

  • MBE, Vikas Shah. Viral Outbreaks & Pandemics. Thought Economics [online]. 2020-03-15 [cit. 2020-03-21]. Dostupné online. (anglicky) 

time.com

  • LEUNG, Hillary. Can You Be Re-Infected After Recovering From Coronavirus? Here's What We Know About COVID-19 Immunity. Time [online]. 2020-04-13 [cit. 2020-10-28]. Dostupné online. (anglicky) 

twitter.com

  • NEILL, James. UPDATE: one in every 75 child cases of COVID-19 are admitted to hospital [online]. 2021-06-12 [cit. 2021-07-23]. Dostupné online. 

uzis.cz

mkn10.uzis.cz

washingtonpost.com

web.archive.org

  • How COVID-19 Spreads [online]. 18 September 2020 [cit. 2020-09-20]. Dostupné v archivu pořízeném z originálu dne 19 September 2020. 
  • The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine [online]. American College of Physicians, 2020-03-10 [cit. 2020-03-25]. Dostupné v archivu pořízeném dne 2020-03-24. ISSN 1539-3704. DOI 10.7326/M20-0504. (anglicky) 
  • Jak se od sebe liší chřipka a koronavirus SARS-CoV-2? [online]. okoronaviru.cz, 2020-03-12 [cit. 2020-10-28]. Dostupné v archivu pořízeném dne 2020-10-17. 
  • HOPKINS, Claire; KUMAR, Nirmal. Loss of sense of smell as marker of COVID-19 infection [online]. ENT UK [cit. 2020-10-28]. Dostupné v archivu pořízeném dne 2020-03-28. (anglicky) 
  • Q&A on coronaviruses [online]. www.who.int [cit. 2020-01-29]. Dostupné v archivu pořízeném z originálu dne 2020-01-20. (anglicky) 
  • Koronavirus 2019-nCoV – informace pro občany. www.mzcr.cz [online]. Ministerstvo zdravotnictví České republiky, 2020-01-26, rev. 2020-02-11 [cit. 2020-02-12]. Existuje vakcína proti koronaviru?. Dostupné v archivu pořízeném dne 2020-02-07. 
  • KORY, Pierre; MEDURI, G. Umberto; IGLESIAS, Jose; VARON, Joseph; MARIK, Paul E. Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19. S. 135–156. Journal of Intensive Care Medicine [online]. 2020-12-15 [cit. 2021-02-26]. Roč. 36, čís. 2, s. 135–156. Dostupné v archivu pořízeném z originálu dne 2021-02-14. DOI 10.1177/0885066620973585. (anglicky) 
  • Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [online]. National Institutes of Health, rev. 2021-02-11 [cit. 2021-03-14]. Kapitola Ivermectin. Dostupné v archivu pořízeném dne 2021-01-19. (anglicky) 
  • Koronavirus 2019-nCoV – informace pro občany. www.mzcr.cz [online]. Ministerstvo zdravotnictví České republiky, 2020-01-26, rev. 2020-02-11 [cit. 2020-02-12]. Jaká je tedy léčba tohoto onemocnění?. Dostupné v archivu pořízeném dne 2020-02-07. 
  • AGOSTINI, Maria L.; ANDRES, Erica L.; SIMS, Amy C.; GRAHAM, Rachel L.; SHEAHAN, Timothy P.; LU, Xiaotao; SMITH, Everett Clinton. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio [online]. 2018-03-06 [cit. 2020-10-27]. Roč. 9, čís. 2. Dostupné v archivu pořízeném z originálu dne 2020-11-01. DOI 10.1128/mBio.00221-18. (anglicky) 
  • IWATA-YOSHIKAWA, Naoko; OKAMURA, Tadashi; SHIMIZU, Yukiko; HASEGAWA, Hideki; TAKEDA, Makoto; NAGATA, Noriyo. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. S. e01815–18, /jvi/93/6/JVI.01815–18.atom. Journal of Virology [online]. 2019-01-09 [cit. 2020-10-28]. Roč. 93, čís. 6, s. e01815–18, /jvi/93/6/JVI.01815–18.atom. Dostupné v archivu pořízeném z originálu dne 2020-11-13. DOI 10.1128/JVI.01815-18. (anglicky) 
  • Aids Info: TMC-310911. aidsinfo.nih.gov [online]. [cit. 2020-06-26]. Dostupné v archivu pořízeném z originálu dne 2020-06-08. 
  • Přehled hodnocených léčiv na nemoc COVID-19, Státní ústav pro kontrolu léčiv [online]. Státní ústav pro kontrolu léčiv, rev. 2020-10-08 [cit. 2020-10-28]. Dostupné v archivu pořízeném dne 2020-10-19. 
  • KÜMPEL, Petr; HOLUB, Michal; ROHÁČOVÁ, Hana. Doporučený postup SIL ČLS JEP léčby pacientů s onemocněním covid-19 [online]. Společnost infekčního lékařství ČLS JEP, 28.8.2020 [cit. 2020-11-18]. Dostupné v archivu pořízeném dne 2020-09-19. 
  • BERAN, J. Použití inosin pranobex v prevenci a léčbě covid-19. Je k dispozici a nepoužívá se. – Proč?. infekce.cz [online]. 2020-04-02 [cit. 2020-12-27]. Dostupné v archivu pořízeném z originálu dne 2021-02-14. 
  • Imunizace proti koronaviru není stoprocentní. Je možné se nakazit opětovně. Czechsight [online]. 4. února 2020 [cit. 2020-04-05]. Dostupné v archivu pořízeném z originálu dne 2020-05-20. 
  • Coronavirus [online]. www.who.int, 2020-01 [cit. 2020-01-24]. Dostupné v archivu pořízeném z originálu dne 2020-01-20. (anglicky) 
  • RITCHIE, Hannah; ROSER, Max. What do we know about the risk of dying from COVID-19? [online]. Redakce Chivers Tom. 25 March 2020 [cit. 2020-03-28]. Dostupné v archivu pořízeném z originálu dne 28 March 2020. 
  • What do we know about the risk of dying from COVID-19? [online]. [cit. 2020-03-28]. Dostupné v archivu pořízeném z originálu dne 28 March 2020. 

who.int

who.int

  • Coronavirus disease (COVID-19): How is it transmitted? [online]. Světová zdravotnická organizace, 2020-07-09, rev. 2020-10-20 [cit. 2021-02-23]. Dostupné online. (anglicky) 
  • Transmission of SARS-CoV-2: implications for infection prevention precautions [online]. Dostupné online. 
  • Q&A on coronaviruses (COVID-19) [online]. WHO, 2020-02-11, rev. 2020-03-09 [cit. 2020-03-25]. Sekce How does COVID-19 spread?. Dostupné online. (anglicky) 
  • Q&A on coronaviruses (COVID-19) [online]. WHO, 2020-02-11, rev. 2020-04-08 [cit. 2020-04-23]. Sekce How long is the incubation period?. Dostupné online. (anglicky) 
  • Q&A on coronaviruses. www.who.int [online]. Světová zdravotnická organizace (WHO), 2020-02-11 [cit. 2020-02-12]. Can 2019-nCoV be caught from a person who presents no symptoms?. Dostupné online. (anglicky) 
  • Q&A on coronaviruses [online]. www.who.int [cit. 2020-01-29]. Dostupné v archivu pořízeném z originálu dne 2020-01-20. (anglicky) 
  • Coronavirus [online]. www.who.int, 2020-01 [cit. 2020-01-24]. Dostupné v archivu pořízeném z originálu dne 2020-01-20. (anglicky) 
  • Coronavirus disease 2019 (COVID-19) Situation Report – 30 [online]. 19 February 2020 [cit. 2020-06-03]. Dostupné online. 
  • Coronavirus disease 2019 (COVID-19) Situation Report – 31 [online]. 20 February 2020 [cit. 2020-04-23]. Dostupné online. 
  • Global Research and Innovation Forum on COVID-19: Virtual Press Conference. www.who.int. World Health Organization, 2 July 2020. Dostupné online. 
  • Estimating mortality from COVID-19 [online]. [cit. 2020-09-21]. Dostupné online. 
  • WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel Coronavirus [online]. Dostupné online. 
  • Smoking and COVID-19 [online]. [cit. 2020-06-19]. Dostupné online. 

apps.who.int

  • RAJAN, Selina; KHUNTI, Kamlesh; ALWAN, Nisreen; STEVES, Claire; GREENHALGH, Trish; MACDERMOTT, Nathalie; SAGAN, Anna. In the wake of the pandemic: Preparing for Long COVID. Policy Brief [online]. Čís. 39. Dostupné online. ISSN 1997-8073. (anglicky) 
  • Background paper on Covid-19 disease and vaccines: prepared by the Strategic Advisory Group of Experts (SAGE) on immunization working group on COVID-19 vaccines [online]. 22 December 2020. Dostupné online. 

euro.who.int

  • COVID-19 weekly surveillance report [online]. [cit. 2020-04-07]. Dostupné online. 

wiley.com

onlinelibrary.wiley.com

  • TANG, Ning; LI, Dengju; WANG, Xiong; SUN, Ziyong. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. S. 844–847. Journal of Thrombosis and Haemostasis [online]. 2020-02-18 [cit. 2020-10-28]. Roč. 18, čís. 4/2020, s. 844–847. Dostupné online. DOI 10.1111/jth.14768. (anglicky) 

worldcat.org

  • Ye Q, Wang B, Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. The Journal of Infection. June 2020, s. 607–613. ISSN 0163-4453. DOI 10.1016/j.jinf.2020.03.037. PMID 32283152. 
  • SHEPHERD, Katie. One person with covid-19 went to work in Oregon. Then, 7 people died and 300 had to quarantine. The Washington Post [online]. 2020-12-23 [cit. 2020-12-27]. Dostupné online. ISSN 0190-8286. (anglicky) 
  • The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine [online]. American College of Physicians, 2020-03-10 [cit. 2020-03-25]. Dostupné v archivu pořízeném dne 2020-03-24. ISSN 1539-3704. DOI 10.7326/M20-0504. (anglicky) 
  • Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open [online]. BMJ Publishing Group, 2020-08-16 [cit. 2021-02-13]. Dostupné online. ISSN 2044-6055. DOI 10.1136/bmjopen-2020-039652. (anglicky) 
  • CHA, Ariana Eunjung. A mysterious blood-clotting complication is killing coronavirus patients. The Washington Post [online]. 2020-04-22 [cit. 2020-10-28]. Dostupné online. ISSN 0190-8286. (anglicky) 
  • CHA, Ariana Eunjung. ‘Frostbite’ toes and other peculiar rashes may be signs of hidden coronavirus infection, especially in the young. The Washington Post [online]. 2020-04-29 [cit. 2020-10-28]. Dostupné online. ISSN 0190-8286. (anglicky) 
  • MCGINLEY, Laurie; JOHNSON, Carolyn Y. FDA pulls emergency approval for antimalarial drugs touted by Trump as covid-19 treatment. The Washington Post [online]. 2020-06-16 [cit. 2020-10-27]. Dostupné online. ISSN 0190-8286. (anglicky) 
  • GAO, Jianjun; TIAN, Zhenxue; YANG, Xu. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. S. 72–73. BioScience Trends [online]. 2020-02-29 [cit. 2020-10-28]. Roč. 14, čís. 1, s. 72–73. Dostupné online. ISSN 1881-7815. DOI 10.5582/bst.2020.01047. (anglicky) 
  • SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 2019-08-01, roč. 36, čís. 8, s. 1878–1905. Dostupné online [cit. 2020-11-18]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764. (anglicky) 
  • THE RECOVERY COLLABORATIVE GROUP. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2020-11-19, roč. 383, čís. 21, s. 2030–2040. Dostupné online [cit. 2021-05-16]. ISSN 0028-4793. DOI 10.1056/NEJMoa2022926. PMID 33031652. (anglicky) 
  • THE RECOVERY COLLABORATIVE GROUP. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2021-02-25, roč. 384, čís. 8, s. 693–704. Dostupné online [cit. 2021-05-16]. ISSN 0028-4793. DOI 10.1056/NEJMoa2021436. PMID 32678530. (anglicky) 
  • THE WHO RAPID EVIDENCE APPRAISAL FOR COVID-19 THERAPIES (REACT) WORKING GROUP; STERNE, Jonathan A. C.; MURTHY, Srinivas. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020-10-06, roč. 324, čís. 13, s. 1330. Dostupné online [cit. 2021-05-16]. ISSN 0098-7484. DOI 10.1001/jama.2020.17023. PMID 32876694. (anglicky) 
  • THOMAS, Katie; WEILAND, Noah. Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval. The New York Times [online]. 2020-11-10 [cit. 2020-12-27]. Dostupné online. ISSN 0362-4331. (anglicky) 
  • ZHANG, Mei-Yun; CHOUDHRY, Vidita; XIAO, Xiaodong; DIMITROV, Dimiter S. Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS. S. 151–156. Current Opinion in Molecular Therapeutics [online]. 2005-04 [cit. 2020-10-28]. Roč. 7, čís. 2, s. 151–156. Dostupné online. ISSN 1464-8431. PMID 15844623. 
  • IKEZAKI, Hiroaki; NOMURA, Hideyuki; SHIMONO, Nobuyuki. Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers. Journal of Infection and Chemotherapy. 2022-06-01, roč. 28, čís. 6, s. 802–805. Dostupné online [cit. 2022-07-17]. ISSN 1341-321X. DOI 10.1016/j.jiac.2022.02.024. (anglicky) 
  • RAJAN, Selina; KHUNTI, Kamlesh; ALWAN, Nisreen; STEVES, Claire; GREENHALGH, Trish; MACDERMOTT, Nathalie; SAGAN, Anna. In the wake of the pandemic: Preparing for Long COVID. Policy Brief [online]. Čís. 39. Dostupné online. ISSN 1997-8073. (anglicky) 
  • DAVIDO, Benjamin; SEANG, Sophie; TUBIANA, Roland. Post–COVID-19 chronic symptoms: a postinfectious entity?. Clinical Microbiology and Infection. 2020-07-23. PMID: 32712242 PMCID: PMC7376333. Dostupné online [cit. 2020-09-07]. ISSN 1198-743X. DOI 10.1016/j.cmi.2020.07.028. PMID 32712242. 
  • BEAUMONT, Peter. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 18 November 2020. Dostupné online [cit. 26 December 2020]. ISSN 0261-3077. 
  • SO, Anthony D; WOO, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. December 2020, s. m4750. ISSN 1756-1833. DOI 10.1136/bmj.m4750. PMID 33323376. 
  • VAN DOREMALEN, Neeltje; BUSHMAKER, Trenton; MORRIS, Dylan H. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020-03-17, roč. 0, čís. 0, s. null. Dostupné online [cit. 2020-04-11]. ISSN 0028-4793. DOI 10.1056/NEJMc2004973. PMID 32182409. 
  • The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19). China CDC Weekly. February 2020, s. 113–122. Dostupné online [cit. 15 June 2020]. ISSN 2096-7071. DOI 10.46234/ccdcw2020.032. 
  • KRISTOF, Nicholas; THOMPSON, Stuart A. Opinion | Trump Wants to ‘Reopen America.’ Here’s What Happens if We Do.. The New York Times. 2020-03-25. Dostupné online [cit. 2020-03-26]. ISSN 0362-4331. (anglicky) 

worldometers.info

  • Coronavirus Symptoms (COVID-19) – Worldometer. www.worldometers.info [online]. [cit. 2020-03-24]. Dostupné online. (anglicky) 

yiigle.com

rs.yiigle.com

  • EPIDEMIOLOGY WORKING GROUP FOR NCIP EPIDEMIC RESPONSE, Chinese Center for Disease Control Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. February 2020, s. 145–151. Dostupné online. DOI 10.3760/cma.j.issn.0254-6450.2020.02.003. PMID 32064853. S2CID 211133882. (čamorsky) 

yookee.cz

  • PÁNIK, Jan: Proč v Česku Covid-19 tolik zabíjí? Vědci popsali závažnou příčinu. Yookee, [6], 4. března 2021.

zdravotnickydenik.cz

  • HAMPLOVÁ, Ludmila. Ivermektin jako soumrak rozumu v době pandemie (část první). Zdravotnický deník [online]. Media Network, 2021-03-07 [cit. 2021-03-09]. Dostupné online.